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The one carbon cycle encompasses the folate and methionine cycles to pro-
duce one carbon units for a variety of cellular processes. The methionine cycle,
in particular, generates S-adenosylmethionine (SAM) from methionine, an es-
sential amino acid. SAM is utilized by histone methyltransferases (HMTs) to
methylate histone proteins. Histone methylation plays diverse roles in the es-
tablishment of chromatin states and the regulation of gene expression. Histones
are methylated by histone methyltransferases (HMTs) and demethylated by hi-
stone demethylases (HDMs) the activities of which rely on molecules generated
via cell metabolism, such as S-adenosylmethionine (SAM). It has been shown
in vitro, physiological concentrations of SAM are close to reported KM values
for histone methyltransferase enzymes. Therefore, histone methyltransferase
activity is sensitive to small changes in intracellular concentrations of SAM that
could arise from differences in nutrient availability.
Histone methylation has only recently been appreciated as a dynamic epi-
genetic mark. Of the numerous histone methylation modifications that oc-
cur, the importance of H3 lysine 4 trimethylation (H3K4me3), H3K9me3, and
H3K27me3 in establishing and maintaining chromatin states and their influence
on gene expression are well documented. To better define the relationship be-
tween SAM availability, histone methylation and downstream consequences on
gene expression, I characterized the metabolic response to methionine restric-
tion using metabolomic, transcriptomic, and epigenomic approaches. Together,
we found a specific response to methionine deprivation lead to decreases in
SAM and H3K4me3 providing a link between cell metabolism and epigenetics.
We took this one step further, and analyzed the transcriptional response to me-
thionine restriction to determine the effect of metabolic alterations in H3K4me3
on gene expression.
This work provides evidence for a link between metabolic status and histone
methylation in cells that could give rise to changes in gene expression−whether
transient or permanent−providing a molecular basis for how environmental fac-
tors, such as diet, can influence gene expression via cell metabolism.
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CHAPTER 1
INTRODUCTION
1.1 Methionine Metabolism
Methionine, an essential amino acid, is transported into the cell via the amino
acid transport system where it is then available for protein synthesis and
metabolic conversion via the methionine cycle (Townsend et al., 2004). The
methionine cycle is part of one carbon metabolism and utilizes methionine to
generate S-adenosylmethionine (SAM). The methyl group in SAM is available
for transfer by methyltransferases like histone methyltransferases (HMTs), pro-
ducing S-adenosylhomocysteine (SAH) in the process. SAH is then converted
to homocysteine which can either enter the transsulfuration pathway or be re-
methylated using 5-methyltetrahydrafolate (5-mTHF) or betaine completing the
cycle to regenerate methionine. The methionine cycle itself is a series of com-
plex biochemical reactions whose enzymes are inhibited and activated by the
metabolites produced in the process (Hoffman et al., 1980; Finkelstein and Mar-
tin, 1984; Finkelstein, 1990). In addition, the methionine cycle provides sub-
strates for polyamine synthesis and the generation of cysteine and glutathione
from the transsulfuration pathway (Finkelstein, 1990). It also provides a link be-
tween folate metabolism and downstream synthesis of purines and pyrimidines
(Figure 1.1). More details on the methionine cycle can be found in Chapter 2.
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Figure 1.1: One Carbon Metabolism
One carbon metabolism is composed of the folate cycle and the methionine cycle,
are connected through remethylation of homocysteine (hCys) by methionine synthase
(MS) utilizing 5-methyltetrahydrofolate (5-mTHF) as a methyl donor to regenerate me-
thionine. One-carbon metabolism, and methionine metabolism in particular, is im-
portant in the generation of S-adenosylmethionine (SAM) for methylation reactions
by methyltransferases (MT). Products of one carbon metabolism are utilized in the
methionine salvage pathway, polyamine synthesis, the transsulfuration pathway and
purine and pyrimidine synthesis. In addition, products of methionine metabolism,
SAM and S-adenosylhomocysteine (SAH), regulate enzyme activity through inhibi-
tion (flat top line) or activation (bold arrow). Methionine (MET); Methionine Adeno-
syltransferase (MAT); Demethylase (DM); S-adeonsylhomocysteine hydrolase (SAHH);
betaine-homocysteine S-methyltransferase (BHMT); Cystathionine (Cys); Cystathio-
nine β-synthase (CBS); tetrahydrafolate (THF); 5,10-methylenetetrahydrofolate (5,10-
meTHF); Serine hydroxymethyltransferase (SHMT).
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Much of the research on methionine metabolism has focused on the methion-
ine cycle in hepatic tissues and cells due to the overwhelming activity observed
there and the expression of CBS and liver specific MAT1A and BHMT1 (Fig-
ure 1.2) (Finkelstein, 1990). In other cells it is likely the transsulfuration pathway
does not play a critical role unless extreme excess of methionine is introduced
to the cell.
Figure 1.2: Methionine Cycle Enzymes
In most cell types, MAT2B, BHMT2, MS, SAHH are located in the cytoplasm and
MAT2A is localized to the cytoplasm and the nucleus. In liver cells, in addition to those
enzymes, BHMT1 and MAT1A are transcribed and localized in the cytoplasm and CBS
is produced and localized in the nucleus.
Understanding the role of methionine metabolism in diverse cell types will
be essential to determine how alterations will effect histone methylation and the
role this relationship plays in disease states. Defects in methionine metabolism
can give rise to a variety of pathologies including liver disease and cancer (Mato
et al., 2008).
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1.2 Histones, Nucleosomes, and Chromatin
Nearly all eukaryotic cells use highly conserved histone proteins to organize
and package DNA into chromatin. Chromatin is composed of repeating nu-
cleosome arrays, in which 147 bp of DNA wraps around a histone octamer
containing two each of the core histones−H3, H4, H2A, and H2B−forming a
nucleosome core (Wood et al., 2005) (Figure 1.3), with linker histones H1 and
linker DNA in between (Kornberg, 1977). The organization of nucleosomes into
higher ordered structures directly impacts the accessibility of the underlying
DNA sequences and therefore, gene expression.
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Figure 1.3: Core Histone Octomer (PDB 1TZY)
Core histone octomer at 1.9 angstrom resolution (PDB Accession 1TZY). Composed two
H2A:H2B dimers and two H3:H4 dimers. Each histone that makes up the core octamer
is labeled with corresponding colors. Protein structure is visualized using Cn3D.
The basic nature of histone proteins facilitates their interaction with the neg-
atively charged DNA backbone in the nucleosome core. Each core histone is
composed of a globular domain, responsible for histone-histone and histone-
DNA interactions, and a mostly unstructured N-terminal tail that protrudes out
from the nucleosome core (Davey et al., 2002; Richmond and Davey, 2003). Al-
though the globular domains can be modified (Feng et al., 2002; Ng et al., 2002;
van Leeuwen et al., 2002; Zhang et al., 2002), the histone tails are more eas-
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ily accessible and can be extensively modified with diverse chemical groups.
Of these, the most commonly studied histone post-translational modifications
(PTMs) are arginine methylation, lysine methylation, acetylation, ubiquitina-
tion, and sumoylation and serine and threonine phosphorylation, although
more novel modifications such has lysine crotonylation and tyrosine hydrox-
ylation, have recently been identified (Tan et al., 2011). In addition, the number
of histone PTMs has only increased with advances in mass spectrometry meth-
ods to include over 125 uniquely modified sites (Tan et al., 2011).
Histone PTMs are thought to act in two ways (1) to change the local chemical
environment, which determines how strong the interaction is between the his-
tones and DNA and (2) recruit proteins that reorganize chromatin and initiate
or repress translation, thus providing a mechanism for gene regulation (Mussel-
man et al., 2012). Since every cell in an organism contains the exact same genetic
code, histones and their PTMs are believed to make up a histone code−a second
set of instructions eukaryotic cells use to maintain their unique identities (Strahl
and Allis, 2000; Jenuwein and Allis, 2001).
1.3 Histone Methylation and Demethylation
Histones can be methylated at the basic residues lysine, arginine, and histi-
dine. In addition, lysine can be mono-, di-, or trimethylated and arginine can
be mono-methylated, or symmetrically or asymmetrically dimethylated (his-
tidine methylation has yet to be characterized). Histone methyltransferases
(HMTs) are the “writers” of methylation marks on histones. All HMTs utilize
the metabolic derived universal methyl donor, S-adenosylmethionine (SAM) to
6
methylate histones, releasing S-adenosylhomocysteine (SAH) in the process.
In addition to histone methyltransferases, “erasers”, or histone demethylases
exist to remove methylation marks from histones and other proteins. Many be-
lieved that histone methylation was permanent until LSD1 (renamed KDM1),
the first histone demethylase, was described by Shi et al. (2004). The mecha-
nism of demethylation involves a deimination reaction to remove the methyl
groups from lysine and arginine. Currently, two types of histone demethy-
lases have been described–Flavin adenine dinucleotide (FAD) dependent and
Jumonji (JmjC) Histone demethylases–and are categorized by the metabolite
co-factors utilized in the demethylation reaction. Flavin adenine dinucleotide
(FAD) dependent demethylases are able to demethylate mono- and dimethy-
lated histones through an amine oxidase reaction.
1.4 The Link Between Metabolism and Epigenetics
Once controversial, it has become appreciated that histone methylation is a dy-
namic process that allows for addition and removal of methyl groups from
histones in response to the environment (Schneider et al., 2002; Zee et al.,
2010). Shyh-Chang et al. (2013) observed decreased H3K4me2 and H3K4me3
after threonine restriction in mouse embryonic stem cells causing decreased
SAM pools. This was followed by experiments showing over-expression of
Nicotinamide N-methyltransferase (NNMT) sequesters SAM away from his-
tone methyltransferase reactions, creating a “methyl sink′′ and reduces H3K4
methylation among others (Ulanovskaya et al., 2013). Shiraki et al. (2014) fol-
lowed up on the original observation by performing similar experiments in hu-
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man embryonic stem cells showing methionine restriction reduces SAM avail-
ability and decreases histone methylation, again with H3K4 methylation being
the most affected. Although in this case, p53 and other stress response path-
ways, which are known to down regulate HMT gene expression, were activated
(Tang et al., 2004). More links were drawn by Tang et al. (2015) that showed
arginine and polyamine synthesis were required for the methionine restriction
response in MCF7 cells and blocking creatine synthesis restored H3K4me3 lev-
els.
1.5 Scope of this Thesis
The link between metabolism and epigenetics is an interesting one that has gar-
nered the attention of many over the past few years, deservedly so. However,
this thesis and current research only scratches the surface of our understand-
ing. Determining the effects of changes in nutrient availability on metabolism
and epigenetics could finally provide a strong link between between the envi-
ronment and our genes and progress in this field could lead to treatments for
diseases, like cancer.
In the following chapter, I explain one potential link between cell metabolism
and epigenetics via one carbon metabolism and histone methylation. The the-
ory details the hypotheses that can be tested; mainly that decreases in nutrient
availability of methionine will decrease SAM availability and thus alter histone
methylation due to the biochemical properties of these reactions.
In chapter 3, these hypotheses are tested using high throughput
metabolomics and NGS sequencing technologies for the first time to detail the
8
metabolic, epigenetic, and transcriptional changes in response to decreased me-
thionine. We provide evidence that one-carbon metabolism is altered in re-
sponse to methionine deprivation in vitro and in vivo and these alterations lead
to decreased H3K4me3. This relationship has the potential to alter key genes
that are important in one carbon metabolism and cancer pathogenesis.
The final appendices detail the scripts used to process the ChIP-seq and
RNA-seq data for reproducibility purposes.
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CHAPTER 2
ONE CARBON METABOLISM: UNDERSTANDING THE SPECIFICITY1
2.1 Summary
One carbon metabolism is a metabolic network that integrates nutrient status
from the environment to yield multiple biological functions. Composed of the
folate and methionine cycle, it generates S-adenosylmethionine (SAM), which
is the universal methyl donor for methylation reactions, including histone and
DNA methylation. Histone methylation is a crucial part of the epigenetic code
and plays diverse roles in the establishment of chromatin states that mediate
the regulation of gene expression. The activities of histone methyltransferases
(HMTs) are dependent on intracellular levels of SAM, which fluctuate based on
cellular nutrient availability, providing a link between cell metabolism and his-
tone methylation. Here we discuss the biochemical properties of and gene regu-
lation by histone methyltransferases and the connection to cellular metabolism.
Our emphasis is on understanding the specificity of this intriguing link.
2.2 Introduction
Studies in a variety of organisms, including humans, have suggested roles for
nutrient metabolism in regulating the epigenetic state in normal and disease
states. Chronic diseases such as diabetes, obesity, cancer, heart disease and ag-
1This chapter has been adapted from our recent publication, Mentch & Locasale, NYAS,
(2016). (Mentch and Locasale, 2016)
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ing all have been linked to metabolic and epigenetic factors that play a role in
pathogenesis (Grandison et al., 2009; Yun et al., 2012; Kraus et al., 2014; Cabreiro
et al., 2013; Ordova´s and Smith, 2010; Benayoun et al., 2015). The maintenance of
cellular homeostasis requires that alterations in nutrient availability be met by
appropriate adaptations. An example is the case of cell proliferation when nu-
trient availability is limiting (Wellen and Thompson, 2010). These adaptations
necessitate sensing mechanisms that can be modulated by nutrient availability
in the environment and communicate metabolic status to affect cellular physi-
ology.
One carbon metabolism utilizes a variety of nutrients such as glucose, vi-
tamins and amino acids to fuel a variety of metabolic pathways that utilize
these one carbon units. These pathways include nucleotide metabolism, main-
tenance of cellular redox status, lipid biosynthesis and methylation metabolism
(Locasale, 2013). Two major components of one carbon metabolism comprise
the folate and methionine cycles (Figure 2.1), that function to transfer single car-
bon units to acceptor substrates. Importantly, the methionine cycle provides
a link to histone methylation through the generation of S-adenosylmethionine
(SAM).
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Figure 2.1: The Methionine Cycle
One carbon metabolism and histone methylation. S-adenosylmethionine (SAM) is
produced from methionine (MET) by Methionine Adenosyltransferase (MAT). His-
tone methyltransferases (HMT) utilize SAM to donate a methyl group to their histone
substrate producing S-adenosylhomocysteine (SAH). Histone demethylases (HDM) re-
move the methyl group from histones returning them to an unmethylated state. SAH
is converted to homocysteine (hCys) via s-adenosylhomocysteine hydrolase (SAHH).
To complete the cycle, SAH can be remethylated to regenerate MET by donation of
a methyl group from the 5-methyltetrahydrafolate (5-mTHF) via methionine synthase
(MS) or from betaine via betaine-homocysteine S-methyltransferase (BHMT).
Histones can be mono-, di-, or trimethylated at lysines and arginines by his-
tone methyltransferases (HMTs), which transfer the methyl group from SAM to
the histone substrate generating SAH (Figure 2.1). Histone methyltransferases
(HMTs) are the ”writers” of methylation marks on histones. Although histone
methylation was discovered in 1964 (Murray, 1964), bona fide HMTs were not
described until 45 years later in 1999 and 2000 with the characterization of Co-
activator Arginine Methyltransferase1 (CARM1) (Chen et al., 1999) and Su-var
16
3-9 Homologue 1 (SUV39H1) (Rea et al., 2000), respectively. Currently, there are
over 30 characterized HMTs with different methylation capacities and speci-
ficities that fall into two families–lysine methyltransferases (KMTs) and protein
arginine methyltransferases (PRMTs).
Methyltransferase activity depends on substrate concentration, as is the case
with all enzymes. However in contrast to phosphorylation kinetics, where ade-
nine triphosphate (ATP) is present in cellular concentrations far greater than
the enzyme KM values (concentration of metabolite at half maximum velocity of
enzyme-mediated reaction), cellular concentrations of SAM are similar to HMT
KM values (Figure 2.2). In addition, SAH is a known inhibitor of HMTs (Deguchi
and Barchas, 1971), suggesting the SAM/SAH ratio may also play a role in the
regulation of HMT activity (Hoffman et al., 1979). Based solely on the biochem-
ical characteristics of HMTs, small fluctuations in SAM concentration could sig-
nificantly affect HMT activity, either increasing or decreasing histone methyla-
tion activity as has been proposed (Locasale and Cantley, 2011). This suggests
a direct link from cell metabolism to histone methylation status exists which
could be tested (Teperino et al., 2010).
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Figure 2.2: Methyltransferase Kinetics
Illustrative example comparing methyltransferase (MT) and kinase kinetics. Methyl-
transferase activity depends heavily on fluctuations of intracellular concentrations of
S-adenosylmethionine (SAM) since MT KM values (concentration of SAM at half maxi-
mum velocity (1/2 Vmax) of the methyltransferase reaction) lie within the range of pos-
sible intracellular SAM concentrations. This is in contrast to kinases, in which activity
is independent of intracellular adenosine triphosphate (ATP) concentration due to high
intracellular concentrations of ATP.
Recent work has shown that altered metabolism does have an effect on his-
tone methylation (Shiraki et al., 2014; Ulanovskaya et al., 2013; Tang et al., 2015),
but the direct mechanistic details have yet to be fully understood. In mouse
embryonic stem cells (mESC), threonine depletion contributed to decreases in
the SAM/SAH ratio and histone H3 lysine 4 trimethylation (H3K4me3). How-
ever, this was observed with many other alterations such as effects on acetyl-
coA metabolism indicating an indirect pathway (Shyh-Chang et al., 2013; Wang
et al., 2009). Additional work on Nicotinamide N-methyltransferase (NNMT),
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a SAM-consuming enzyme demonstrated over expression decreased SAM and
increased SAH, overall decreasing the SAM/SAH ratio and decreasing histone
methylation at H3K9me2 and H3K27me3 (Ulanovskaya et al., 2013). Further,
methionine deprivation in human stem cells decreased H3K4me3 but the obser-
vation was due in part to indirect mechanisms involving an activation of a stress
response, apoptotic, and differentiation pathways (Shiraki et al., 2014). Despite
these advances in our understanding, the precise molecular mechanisms and
specific effects on gene expression have been largely uncharacterized.
In this review we will focus on methionine metabolism as an essential reg-
ulator of histone methylation and the possibility for specific gene regulation
determined by the biochemical properties, specificities of HMTs and the avail-
ability of the cofactor SAM. We will concentrate on histone lysine methylation
because of its importance in epigenetics and its dysregulation in disease states.
2.3 Methionine and One Carbon Metabolism
The methionine cycle is essential for the generation of SAM through the adeny-
lation of methionine by methionine adenosyltransferase (MAT) (Finkelstein,
1990; Cantoni, 1953; De La Haba and Cantoni, 1959). SAM is considered the
universal methyl donor and is used by methyltransferases to methylate metabo-
lites, RNA, DNA, and proteins, including histones. After the methyl group is
transferred from SAM to an acceptor substrate, S-adenosylhomocysteine (SAH)
is produced. In turn, SAH is hydrolyzed to adenine and homocysteine. In
vivo, the reaction kinetics proceed forward in this direction, as long as the
products are being removed through other metabolic pathways. Otherwise,
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the reverse reaction is more favorable increasing the pool of SAH (De La Haba
and Cantoni, 1959). Homocysteine can enter the transulfuration pathway and
condense with serine to generate cystathionine in an irreversible reaction cat-
alyzed by cystathionine-β-synthase (CBS). In addition, two enzymes can uti-
lize homocysteine to regenerate methionine. Betaine-homocysteine methyl-
transferases (BHMT) transfers a methyl group from betaine, an intermediate in
choline metabolism, to regenerate methionine and produce dimethylglycine. 5-
methyltetrahydrofolate-homocysteine methyltransferase (MS) regenerates me-
thionine by the transfer of the 5-methyltetrahydrofolate methyl moiety to ho-
mocysteine producing tetrahydrofolate (THF).
The amount of intracellular SAM depends largely on the availability of me-
thionine, an essential amino acid sourced from the diet. The concentration of
methionine circulating throughout the body in the serum is around 30µM in
adults but may vary widely and change with disease (Cynober, 2002; Psycho-
gios et al., 2011). It was recently found that methionine was observed to be the
most variable serum amino acid with dietary factors being a major source of the
variation (Mentch et al., 2015). SAM concentration, on the other hand, is very
low in the serum (<0.5µM) (Melnyk et al., 2000) and is contained mostly in intra-
cellular pools ranging from below 10µM up to 90µM under normal conditions
and is dependent on tissue type (Duncan et al., 2013).
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2.4 Histone Methyltransferases and Their Biochemical
Properties
Histones can be methylated at basic residues, most notably, lysine and argi-
nine. In addition, lysine can be mono-, di-, or trimethylated and arginine can be
mono-methylated, or symmetrically or asymmetrically dimethylated. All char-
acterized lysine-specific methyltransferases contain a SET (Su(var), Enhancer
of Zeste and Trithorax) domain except Disruptor of Telomeric Silencing-like 1
(DOT1L), which methylates the globular domain of H3 at Lysine 79 (H3K79)
putatively only when the nucleosome is intact (Feng et al., 2002). The SET do-
main spans 130 amino acids forming a tunnel that connects the cofactor binding
site to the substrate binding site on the opposite side. This lysine access chan-
nel determines the number of methyl groups that can be transferred during a
reaction for a given HMT and depends on the position of the methylated lysine
(Figure 2.3) (Xiao et al., 2003; Dolinsky et al., 2004).
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Figure 2.3: Histone Methyltransferase Structure and Binding
(A) Surface model demonstrates SAH binding and the lysine access channel with a
methylated H3 tail within the SET domain of KMT730 (RCSB 1O9S) (B) The lysine
access channel colored according to its electrostatic potential calculated by PDB2PQR
2.031 (C) Surface view of active site; Lysine 4 of the H3 tail enters through the lysine
access channel approaching the active site containing SAH
Before transfer, the -amino group on the lysine substrate is deprotonated
and points towards the SAM methyl group at 180◦ suggesting an SN2 reaction
mechanism of transfer. No matter the type of HMT, they utilize the univer-
sal methyl donor, S-adenosylmethionine (SAM) to methylate histones releasing
S-adenosylhomocysteine (SAH) in the process allowing for regulation by cell
metabolism.
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The regulation of HMT activity would depend on the processing of methio-
nine to form SAM, SAM availability to HMTs, and the concentration of HMTs
in the cell. Many HMTs have been carefully studied and characterized (Sum-
marized in Table 2.4). Interestingly, the KM, SAM for the methylation reactions
performed by HMTs falls within the range of observed intracellular SAM con-
centrations. Notably, there is also range of kinetic parameters across the family
of HMTs suggesting that a change in metabolic flux would affect only select
HMT activity.
Table 2.1: Kinetic Properties of Histone Methyltransferases
Residue HMT Modification KM(SAM) [µM] References
H3K4 KMT2A (MLL1) me1/2/3 10.4 ± 3.1 (Patel et al., 2014)
KMT2B (MLL2) me1/2/3 4.5 ± 0.82 (Horiuchi et al., 2013)
KMT2C (MLL3) me1/2/3 0.85 ± 0.19 (Horiuchi et al., 2013)
KMT7 (SET7/9) me3 6.0 ± 1.4 (Xiao et al., 2003)
H3K9 KMT1A (SUV39H1) me1/2 12.3 ± 0.6 (Chin et al., 2005)
KMT1B (SUV39H2) me1/2 0.74 ± 0.23 (Horiuchi et al., 2013)
KMT1C (EHMT2) me2/3 1.8 ± 0.2 (Patnaik et al., 2004)
H3K27 EZH1 me1/2/3 1.24 ± 0.15 (Horiuchi et al., 2013)
KMT6 (EZH2) me1/2/3 1.64 ± 0.26 (Horiuchi et al., 2013)
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2.5 Histone Methylation Readers, Chromatin Organization,
and Gene Expression
Lysine methylation does not significantly alter the local chemical environment
and leads to modest if not insignificant changes in DNA and gene accessibility,
in contrast to acetylation and phosphorylation. Therefore, ”readers” of histone
methylation are important since they are able to bind specific histone methyla-
tion marks to propagate their effects to gene expression (Musselman et al., 2012).
Several conserved histone methyl binding motifs are categorized broadly into
two groups, those containing Chromodomains and those that are part of the
Royal superfamily (Musselman et al., 2012; Taverna et al., 2007). These domains
are present in ”reader” proteins that bind histone methylation sites, like CHD1
(chromodomain helices DNA-bnding protein 1) (Pray-Grant et al., 2005), HP1
(heterochromatin protein 1) (Bannister et al., 2001), PC (polycomb protein) (Cao
et al., 2002), and p53BP1 (p53-binding protein 1) (Huyen et al., 2004) which
allow HMTs to regulate a range of cellular processes including, transcription,
RNA processing, and DNA methylation, all of which affect gene expression by
chromatin remodeling and transcriptional machinery recruitment.
With the advances in sequencing and chromatin immunoprecipitation
(ChIP), we now have a vast repository of data showing the genomic locations
of associated proteins including modified histones (Koch et al., 2007; Roadmap
et al., 2015; Birney et al., 2007; Barski et al., 2007). H3K4me3 has been shown to
correlate well with active gene transcription and is concentrated around tran-
scriptional start sites (Noma and Grewal, 2002; Bernstein et al., 2002). ChIP-seq
has confirmed earlier studies and consistently identifies H3K4me3 at promoters
24
as a predictive mark of actively transcribed genes (Birney et al., 2007). Recent
analyses have also identified the shape of the peak around the transcriptional
start site to be a major feature of genes involved in key biological processes
such as aging and tumor suppression (Chen et al., 2015; Benayoun et al., 2014).
H3K4me3 is recognized by TAF3 (TATA Box Binding Protein (TBP) Associated
Factor, 140kD) a subunit of TFIID (Transcription Factor II D) suggesting a broad
role in RNAP II dependent gene transcription (van Ingen et al., 2008). In addi-
tion, H3K4me1 has been implicated in marking enhancer regions and depletion
at enhancers abolishes long range effects on gene regulation (Herz et al., 2012).
H3K9 methylation, participates in both constitutive and facultative hete-
rochromatin formation and maintenance (Nakayama et al., 2001; Noma et al.,
2001; Peters et al., 2002, 2001). HP1 is recruited to sites of H3K9me3 by inter-
actions with the trimethyl moiety on H3K9 and SUV39H1 (Stewart et al., 2005).
HP1 then forms a multimeric complex as SUV39H1 methylates more H3K9 re-
cruiting more HP1 in a positive feedback loop that continues to maintain these
heterochromatin regions (Lachner et al., 2001).
In addition, H3K27me is correlated with gene inactivation and silencing
(Barski et al., 2007). In contrast to other histone methylation events, only two
enzymes (EZH1 and EZH2) methylate H3K27 and both are associated with the
Polycomb Repressive Complexes (PRCs) (Abel et al., 1996). The PRC is respon-
sible for transcriptional repression by ubiquitination of Histone H2A Lysine
119 (H2A119ub1) (Wang et al., 2004), recruitment of DNA methyltransferases
(DNMTs) (Vire´ et al., 2006) and chromatin compaction (Francis et al., 2004).
Thus with each of these types of regulation by different histone methylation
events, metabolism offers several selective modes of interaction to mediate hi-
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stone methylation and downstream consequences. For instance, a change in
SAM levels could trigger a cascade that would propagate through the activity
of the HMTs to the recruitment of readers to reach the end point of differential
gene expression.
2.6 Histone Methyltransferases and Their Target Genes
Genetic studies in Drosophila identified two groups of genes that suppress and
enhance the position-effect variegation phenotype, referred to as the trithorax
(trx) and Polycomb (Pc) genes, respectively (Stassen et al., 1995; Tschiersch et al.,
1994). Many of these genes encode proteins, which contain a SET domain. SET1,
the first identified HMT with a SET domain was characterized in yeast and fur-
ther studies identified the Complex of Proteins Associated with SET1 (COM-
PASS) (Miller et al., 2001; Krogan et al., 2002). In humans there are two ho-
mologous complexes that associate with SET1a and SET1b in addition to four
COMPASS-like complexes that associate with MLL1-4 (Shilatifard, 2012).
SET1 is recruited to actively transcribed genes by an interaction at the C-
terminal Domain (CTD) of RNAPII during elongation and is responsible for
broader H3K4me3 marking across the gene (Ng et al., 2003; Wu et al., 2008). In
humans, SET1a and SET1b localize to different euchromatic structures within
the nucleus suggesting distinct roles in regulating gene expression (Lee et al.,
2007). RNAi-mediated knockdown of Set1a decreased promoter H3K4me2 ac-
companied by decreased expression of oncogenes, Myc and BRCA1 (Nguyen
et al., 2008).
The MLL family of histone methyltransferases was identified in humans be-
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cause of their significant role in Leukemias (Krivtsov and Armstrong, 2007).
MLL-1 is present at active promoters with 90% overlap with RNAPII suggesting
a broad role in regulating active transcription (Guenther et al., 2005). In addi-
tion, ChIP-chip experiments suggest a specific role in regulating miRNAs and
the late HoxA cluster (HoxA7, HoxA9, HoxA10, HoxA11, and HoxA13) (Guen-
ther et al., 2005). In contrast, MLL-2 and MLL-3 do not alter bulk H3K4me3
after more than 80% knockdown (Hu et al., 2013). Instead, MLL-2 seems to func-
tions at developmentally regulated genes with characteristic bivalent promoters
marked by H3K27me3 and H3K4me3 including all four Hox gene clusters (Hu
et al., 2013). ChIP-seq analysis of MLL4 demonstrated a unique subset of en-
hancers that are dynamically regulated by MLL4 mono- and dimethylation at
different points during differentiation (Lee et al., 2013). MLL4 co-localizes with
transcription factors (PPARγ and C/EBPs) that determine cell lineage during
adipogenesis. In addition, deletion of MLL4 decreases H3K4me1, H3K4me2,
RNAPII and Mediator occupancy at active enhancers.
H3K9 methyltransferases belong to the KMT1 family with the exception of
PRDM2 (KMT8). Supressor of Variegation 3-9 Homolog 1 (SUV39H1) and 2
(SUV39H2) have redundant function and methylate pericentric regions to main-
tain chromatin organization (Peters et al., 2001). On the other hand, H3K9 Eu-
chromatic Histone-Lysine N-Methyltransferase 2 (EHMT2/KMT1C) ChIP-seq
data shows enrichment at developmental genes and co-localization with PRC2
at a subset of genes suggesting cross talk between H3K9me and H3K27me. In-
terestingly, co-localization of EHMT2 and PRC2 subunits are enriched at genes
important in neuronal development. (Mozzetta et al., 2014) Lastly, H3K27
methylation occurs via EZH1 or EZH2. In mouse hair follicle, single mutants
EZH1-/- or EZH2-/- showed no phenotypic difference, suggesting functional
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redundancy as concluded by the authors. However a group of genes associated
with cell cycle progression, cell death and regulation of biological/cellular pro-
cesses had increased expression and decreased H3K27me2/3 after knockdown
of EZH2 by siRNA (McCabe et al., 2012).
The activity of each of these enzymes is affected differently by the availabil-
ity of methionine and status of one carbon metabolism. In each of the genetic
studies, it is tempting to speculate that the observed phenotypes that demon-
strate the requirements of each HMT would depend on the nutritional environ-
ment and metabolic status of the experimental background. For example, in
conditions of SAM levels, one might observe different dependencies of differ-
ent MLL enzymes with differential requirements on the maintenance of histone
methylation. Furthermore, the target list of genes mediated by these enzymes
may be grossly different in conditions of different one carbon metabolism since
it is likely that the marks surrounding a given gene would not be altered in an
identical manner to what would be observed in a neighboring gene. Compara-
tive ChIP-seq analysis is likely to reveal new principles into how this specificity
would be maintained.
2.7 Conclusions
While some HMTs appear to exhibit regulation of broad chromatin regions (ex.
MLL1), most have demonstrated a preference for a subset of genes that are
specifically regulated. Since the activity of each HMT is also governed by sub-
strate availability (SAM or histone), gene specific regulation is likely altered
under different metabolic conditions. For example, if the SAM concentration is
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suppressed due to insufficient amounts of methionine and choline in the diet,
this change in the intracellular concentration of SAM would in turn decrease the
activity of a subset of methyltransferases based on SAM KM values and other
relevant kinetic parameters. In this regard, KMT2A (MLL1), with a KM, SAM
of 12.3µM, should be more affected by decreases in SAM than EZH1, with a
KM,SAM of 1.24µM. This could have specific consequences on gene expression.
Since MLL1 is a general H3K4me3 methyltransferase, one might hypothesize
an overall decrease in H3K4me3 deposition across the genome specifically at
promoter regions while H3K27me3 is largely unaffected. The loss of H3K4me3
at promoters has been linked to decreases in Transcription Factor II D (TFIID)
binding, an important player in Pol II recruitment, through its TAF3 subunit,
ultimately leading to decreased gene expression (Vermeulen et al., 2007). Al-
though there are many factors to consider in this regulation, mathematical mod-
eling allows one to parse many simultaneous interactions and would be a use-
ful tool to determine the contribution of each HMT to the regulation of global
and specific gene expression. It will be important to determine how methion-
ine metabolism is altered in different physiological states, (dieting, cancer, etc.),
and the consequences on histone methylation and gene expression to determine
the specificity of this sensing mechanism. Future work providing deeper mech-
anistic connections between metabolism and epigenetics will provide insight
into the link between metabolic status, histone methylation and the effect on
gene expression–whether transient or permanent–providing a molecular basis
for how environmental factors, such as diet, can influence gene expression via
cell metabolism.
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CHAPTER 3
REGULATION OF HISTONE METHYLATION VIA METHIONINE
METABOLISM1
3.1 Summary
S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) link one car-
bon metabolism to methylation status. However, it is unknown whether regula-
tion of SAM and SAH by nutrient availability can be directly sensed to alter the
kinetics of key histone methylation marks. We provide evidence that the status
of methionine metabolism is sufficient to determine levels of histone methy-
lation by modulating SAM and SAH. This dynamic interaction led to rapid
changes in H3K4me3, altered gene transcription, provided feedback regulation
to one carbon metabolism, and could be fully recovered upon restoration of me-
thionine. Modulation of methionine in diet led to changes in metabolism and
histone methylation in the liver. In humans, methionine variability in fasting
serum was commensurate with concentrations needed for these dynamics and
could be partly explained by diet. Together these findings demonstrate that flux
through methionine metabolism and the sensing of methionine availability may
allow direct communication to the chromatin state in cells.
1This chapter has been adapted from our recent publication, Mentch, et al., Cell
Metabolism, (2015). (Mentch et al., 2015)
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3.2 Introduction
Alterations in the methylation status of proteins, nucleic acids, and metabolites
contribute to the pathogenesis of many of the major human pathophysiologi-
cal conditions including cancer, obesity, and aging (Bergman and Cedar, 2013;
Greer and Shi, 2012; Kraus et al., 2014). When these changes affect the methy-
lation of histones and nucleic acids that determine the epigenetic status in cells,
they can affect the expression of thousands of genes (Barth and Imhof, 2010).
Changes in methylation status occur due to differences in the enzyme activ-
ity of methyltransferases and demethylases. Genes that encode these enzymes
are frequently altered in pathological states leading to alterations in methyla-
tion (Chi et al., 2010; Dawson and Kouzarides, 2012). It has also been long es-
tablished that S-adenosylmethionine (SAM) is the universal methyl donor for
these enzymes that transfer its methyl group to yield S-adenosylhomocysteine
(SAH) and a methylated substrate (Finkelstein, 1990). The methylation of this
substrate provides a link between the metabolism that regulates SAM and SAH,
which may act through product inhibition of a methyltransferase, and the epi-
genetic status of cells (Gut and Verdin, 2013; Katada et al., 2012; Teperino et al.,
2010).
SAM and SAH are intermediate metabolites in a metabolic pathway that is a
subset of a larger network collectively referred to as one carbon metabolism (Lo-
casale, 2013). One carbon metabolism integrates nutrients from diverse sources
such as glucose, serine, threonine, methionine, and choline and processes them
into distinct outputs that achieve diverse biological functions. Whether the con-
centrations of SAM and SAH or their ratio ever reach physiological values that
could affect methyltransferase activity has been controversial. Some studies
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have concluded that their concentrations do not reach limiting values (Hoff-
man et al., 1979). Recent studies however have provided evidence that under
pathological conditions aberrant expression of NNMT, an enzyme that metab-
olizes SAM, has profound biological consequences resulting from changes in
histone methylation (Kraus et al., 2014; Ulanovskaya et al., 2013). Others have
found that only the levels of SAH correlated with methylation status includ-
ing a recent finding that investigated threonine metabolism in mouse pluripo-
tent stem cells that demonstrated threonine catabolism affected both pyruvate
and glycine metabolism and altered histone methylation (Shyh-Chang et al.,
2013). Although this study was the first to our knowledge to document the
influence of an amino acid on histone methylation, this effect was shown to
occur through indirect pathways involving energy production and acetyl-coA
metabolism. Further studies have demonstrated in human pluripotent stem
cells that a depletion of methionine that is the precursor to SAM could lead to
changes in histone methylation (Shiraki et al., 2014). However, these changes are
also accompanied by widespread induction of stress response pathways and cell
death confounding the interpretation of whether the changes in histone methy-
lation occurred directly through the sensing of SAM/SAH status.
Given these previous findings, we hypothesized that there exists a direct
mechanism whereby the status of one carbon metabolism could alter the con-
centrations of SAM and SAH to confer, through their interaction with methyl-
transferases, the output of a defined methylation state. We focused on histones
since key methylation modifications on their tails such as trimethylation at Ly-
sine 4 are known to be required for the maintenance of defined cellular states
(Benayoun et al., 2014; Ruthenburg et al., 2007) and have been shown to be
modulated by metabolism (Shiraki et al., 2014; Shyh-Chang et al., 2013). We
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provide evidence in cells and mice that both SAM levels and the SAM/SAH
ratio can be quantitatively tuned through changes in the metabolic flux of the
methionine cycle to affect a critical component of chromatin status. This regula-
tion occurred at physiologically relevant concentrations and appeared to control
numerous physiological processes including direct feedback regulation for the
maintenance of homeostasis in one carbon metabolism and the activity of genes
involved in cancer and cell fate. Together these findings are consistent with a
model whereby the status of one carbon metabolism is in communication with
the chromatin state of cells through its ability to modify the kinetics of enzymes
that mediate histone methylation.
3.3 Results
3.3.1 Methionine Metabolism Quantitatively Affects Histone
Methylation
Since methionine is the closest substrate in the methionine cycle and one carbon
metabolism that affects SAM levels, we therefore tested whether cells depleted
of methionine have alterations in the methionine cycle and whether this would
confer effects on the methylation of histones. We generated a media formula-
tion in which methionine was restricted from the culture media. HCT116 cells
were placed in this methionine restricted (3µM) media for 24 hours. We then uti-
lized a liquid chromatography, high-resolution mass spectrometry (LC-HRMS)
metabolomics technology we have recently developed (Liu et al., 2014a,b) to
generate a quantitative profile of over 300 metabolites in response to methion-
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ine restriction that is visualized in a volcano plot (Figure 3.1A). It was found that
metabolites in the methionine cycle exhibited dramatic changes in their concen-
trations with only moderate compensation from other pathways that fuel the
one carbon cycle (Figure 3.1B).
Figure 3.1: Metabolic Alterations After Methionine Restriction
(A) Metabolomics profile of HCT116 cells after 24 hours of methionine restriction. Log 2
change versus -log 10(p-value), Student’s two-tailed t-test, n=3. (B) Effects of methion-
ine restriction on one carbon cycle metabolism.
Notably, both SAM and SAH are depleted under these conditions.
To test whether these alterations were sufficient to induce changes in histone
methylation, we considered the relative levels of several histone methylation
marks involving trimethylation at lysines 4,9, 27 that are each known to have
substantial roles defining chromatin states, most notably at active and inactive
genes, and mediating gene expression (Shilatifard, 2006) (Figure 3.2).
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Figure 3.2: Histone Methylation Depleted After Methionine Restriction
Nuclear extracts from methionine restricted HCT116 cells were blotted for H3K4me3,
H3K9me3, and H3K27me3 and imaged using a ChemiDoc. Band intensities are nor-
malized to total H3 and fold change was calculated.
In addition, the kinetic properties, such as SAM binding affinity (KM), of
these histone methyltransferases (An et al., 2011; Chin et al., 2005; Horiuchi
et al., 2013; Obianyo et al., 2008; Patnaik et al., 2004; Xiao et al., 2003) suggests
SAM concentration may play a role in their regulation and directly affect the
rate of histone methylation reactions in the cell (Figure 3.3).
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Figure 3.3: Published Histone Methyltransferase KM Parameters
Published histone methyltransferase kinetic parameters from several sources catego-
rized by histone substrate (H3K4, H3K9, and H3K27) or other.
Each modification exhibited decreased methylation with trimethylation at
lysine 4 on histone H3 (H3K4me3) exhibiting the largest change. To investigate
whether these changes were specific to methionine restriction, we considered
the removal of several other amino acids (W, Q, K, H, L) that include essential
amino acids and glutamine that has been shown to be essential for cell prolifer-
ation (Figure 3.4).
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Figure 3.4: No Significant Changes in Histone Methylation after Indi-
vidual Essential Amino Acid Restriction
HCT116 cells were grown in conditional media lacking one of five essential amino acids
(W, Q, K, H, or L) and western blot was used to determine the change in histone methy-
lation. Bands were normalized to total H3 protein and a fold change was calculated for
each amino acid deprivation experiment.
We found that in each case no change in histone methylation was observed.
To further test the generality of this observation, we considered the response of
H3K4me3 to methionine restriction on a panel of six human cell lines subjected
to methionine restriction for 24 hours (Figure 3.5A). Metabolomics across the
cell panel revealed methionine cycle metabolism and purine and pyrimidine
metabolism decreased significantly for all cell lines (Figure 3.5B). In addition,
fatty acid metabolism and serine/glycine metabolism significantly increased
across all cell lines tested (Figure 3.5C).
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Figure 3.5: Metabolic Response to Methionine Restriction in Colon
Cancer Cell Line Panel
After 24 hours of methionine restriction, metabolites were collected from a panel
of colon cancer cell lines (SQ620, SW480, HCT8, HT29, HCT116, NCI-H5087) and
metabolomics was performed. (A) Volcano plot highlighting metabolic modules that
are significantly altered after methionine restriction. Log2 change versus -Log10(p-
value), Student’s two-tailed t-test using Holm-Sidak multiple testing correction pro-
cedure, α = 0.5 , n = 18. Significant pathway enrichment determined using MetaboAn-
alyst. (B) Metabolites that are significantly decreased after methionine restriction. (C)
Metabolites that are significantly increased after methionine restriction. Methionine &
Cysteine Metabolism (Met, Cys); Tricarboxylic Acid Cycle (TCA); Purine & Pyrimidine
Metabolism (Pur, Pyr); Serine & Glycne Metabolism (Ser, Gly).
Next, we tested how H3K4me3 responded to methionine restriction across
the cell line panel. In each case, H3K4me3 was responsive to methionine restric-
tion (Figure 3.6).
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Figure 3.6: Colon Cancer Cell Line Panel Response to Methionine Re-
striction
After 24 hours of methionine restriction, histone lysates from a panel of colon cancer
cell lines were collected and blotted for histone methylation marks and imaged using a
ChemiDoc. Band intensities were normalized to total H3. Coomassie staining of total
protein input is shown as a loading control.
Having shown that extreme restriction of methionine is sufficient to alter hi-
stone methylation, we investigated the concentration of methionine needed to
achieve this effect. We considered a titration of differing concentrations of me-
thionine in the culture media ranging from 3 to 500 µM. The relative levels of the
methionine cycle and one carbon metabolism-related metabolites including me-
thionine, SAM, SAH, homocysteine, betaine, and dimethylglycine (DMG) were
measured (Figure 3.7A). It was found that the levels of these intermediates ex-
hibited a graded response to changes in methionine concentration in the media.
SAM and SAH were altered at concentrations below 25 µM - concentrations well
below those present in typical culture media. We next investigated the dose re-
sponse of changes in histone methylation to changes in methionine availability
(Figure 3.7B). Histone methylation responded differently to differing concentra-
tions of methionine. H3K4me3 was affected at concentrations between 10 and
25 µM consistent with concentrations needed to deplete SAM and SAH in the
methionine cycle.
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Figure 3.7: The Effects of Methionine Concentration on the Methionine
Cycle and Histone Methylation
(A). Relative concentrations of methionine cycle metabolites in cells cultured at differ-
ent concentrations of methionine. (B) Concentration-dependent effects of methionine
restriction on histone methylation. Data are normalized to the 100µM condition.
One possibility is that these changes were due to non-specific effects on cell
proliferation. We therefore considered the effects of methionine restriction on
cell proliferation over a course of three days (Figure 3.8A, 3.8B). At low concen-
trations of methionine, there were marked defects in cell morphology and cell
proliferation but no activation of p53 when H3K4me3 is changing (Figure 3.8B,
3.8C) indicating that H3K4me3 dynamics occur before a cellular stress response.
At 10 µM, cells remained viable with no gross alterations in morphology and
only a modest decrease in cell proliferation that was fully recoverable at 25 µM
confirming that the changes in histone methylation are not likely due to defects
in cell proliferation. Together these findings demonstrate that methionine af-
fects histone methylation and the dynamics of the methionine cycle.
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Figure 3.8: The Effects of Methionine Concentration on Cell Growth
and Morphology
(A) HCT116 cell proliferation at different levels of methionine. All error bars are com-
puted from standard error of measurement (n=3).(B) Cell morphology in response to
different levels of methionine restriction at different days. (C) p53 response after me-
thionine restriction or 5-FU treatment in HCT116 cells.
3.3.2 Methionine Cycle and Histone Methylation Dynamics in
Response to Methionine Restriction
Having observed alterations in the methionine cycle and concomitant changes
in histone methylation, we sought to understand the dynamics of the process
and its connection to cellular metabolism. We reasoned that the kinetics could
provide further insights into how changes in metabolism alter histone methy-
lation. We considered the metabolic dynamics of methionine restriction across
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twelve time points (0, 5, 15, 30, 60, 90, 120, 240, 360, 540, 720, and 1440 min-
utes) from very early time up to times leading to cell death (Figure 3.9A). At
each of these time points, we profiled over 300 metabolites spanning pathways
across central carbon and secondary metabolism. A hierarchical clustering of
the time course revealed coordinated dynamics across the metabolome in re-
sponse to methionine restriction. Waves of coordinated changes that involve
different metabolic pathways were observed.
We utilized a recently developed algorithm for assessing the contribution to
different pathways (i.e. pathway impact) defined by the Kyoto Encyclopedia
of Genes and Genomes (KEGG) (Xia and Wishart, 2010) (Figure 3.9B). Path-
way impact is computed by considering a weighted score of each metabolite
with greater weights being assigned to metabolites that are centrally located
in a given metabolic pathway. At early times, a module related to cysteine
and methionine metabolism exhibited decreasing dynamics that were sustained
across the time course. At intermediate times alterations in metabolites belong-
ing to phenylalanine, tryptophan, and lysine metabolism were observed. At
later times arginine and proline metabolism appeared altered together suggest-
ing that a complex compensatory amino acid response at later times occurs after
the primary response to methionine restriction.
A further inspection of the module related to methionine cycle dynamics
revealed that within minutes of methionine restriction, methionine is depleted
within cells (Figure 3.9C). SAM levels exhibited a decay that occurred within
an hour (Figure 3.9D). SAH levels exhibited more complex behavior involving
a fast decrease, a recovery at two hours and a later decrease (Figure 3.9E). These
dynamics are likely due to additional pathways such as remethylation from one
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carbon metabolism, methionine salvage, and flux into the transsulfuration path-
way. These changes contributed to complicated dynamics of the SAM/SAH
ratio that decreased at two hours (Figure 3.9F).
We next monitored the dynamics of histone methylation to assess its inter-
action with metabolic dynamics. We considered the dynamics of the levels of
H3K4/9/27 in response to methionine restriction (Figure 3.9G,H). Surprisingly,
it was found that within two to four hours, a depletion of histone methyla-
tion was observed. These kinetics exhibited only a one to two hour lag be-
tween depletion of the methionine cycle and the subsequent changes in histone
methylation. These dynamics are generally too short for a transcriptional or
translational regulatory response. Together these findings conclude that the dy-
namics of methionine metabolism result primarily in amino acid compensatory
responses and not general features that result in disruption of cell proliferation.
They also indicate that methionine dynamics can be coordinately sensed by hi-
stones to determine the levels of histone methylation.
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Figure 3.9: Histone Methylation is Dynamically Regulated by Methio-
nine Metabolism
(A) Global metabolic dynamics in response to methionine restriction over a 24 hour
time course. (B) Pathway analysis of methionine cycle dynamics show in (A). (C) Dy-
namics of methionine over 24 hours of methionine restriction. (D) Dynamics of SAM
over 24 hours of methionine restriction. (E) Dynamics of SAH over 24 hours of me-
thionine restriction. (F) Dynamics of the SAM/SAH ratio over 24 hours of methionine
restriction. (G) Dynamics of histone methylation in response to methionine restriction
over 24 hours. (H) Quantification of results in (G) and two other independent experi-
ments. Integrated intestines are normalized to total H3, and the fold change represents
the differences compared with 24 hours. All error bars are computed from SEM (n=3).
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3.3.3 Methionine Metabolism and Histone Methylation
Dynamics Are Reversible
Thus far we have shown that methionine metabolism can induce alterations in
histone methylation levels and that this effect is dynamic and occurs on time
scales consistent with that of a direct sensing mechanism. Another necessary
requirement of such a signal transduction mechanism is that the dynamics are
reversible. We therefore questioned whether metabolism and histone methyla-
tion can be recovered after methionine restriction. Cells were subjected to me-
thionine restriction for 24 hours (between day 1 and day 2) at which point we
allowed the cells to be cultured for an additional 24 hours in media containing
the full concentration of methionine (between day 2 and day 3) (Figure 3.10).
Figure 3.10: Methionine Cycle Rescue
Experimental setup of methionine restriction and recovery. HCT116 cells were grown
in -MET media for 24 hours then switched to +MET media for an additional 24 hours.
Samples were collected on day 1, day 2 (MET dropout), and day 3 (MET rescue).
We carried out metabolomics at each time point as considered previously
(Figure 3.11A). Hierarchical clustering of each profile revealed marked changes
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across the metabolic network at days 1, 2, and 3. The gross measured differ-
ences in metabolism from day 1 and day 3 revealed that overall metabolism is
not reversible under these conditions. An assessment of the pathways involved
indicated that several amino acid metabolism pathways were not recoverable
at 3 days (Figure 3.11B). Of the pathways recovered after reincorporation of
methionine into the culture media, cysteine and methionine metabolism was
one of three pathways shown to be reversible. This effect is illustrated in Fig-
ure 3.11C where the methionine cycle is plotted and for each metabolite in the
cycle, some recovery of its concentration and the concentration of the metabo-
lites in its salvage and the transsulfuration pathways (Figure 3.11D, E) was ob-
served. To investigate whether these dynamics correlate with histone methy-
lation we measured histone methylation levels (Figure 3.11F) and found that
methylation levels exhibited a concomitant recovery back to levels observed in
the original culture conditions.
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Figure 3.11: Histone Methylation and Methionine Cycle Dynamics are
Reversible
(A) Effects of methionine restriction and recovery on global metabolism. (B) Metabolic
pathway analysis of methionine restriction and recovery. (C) Effects of methionine re-
striction and recovery on methionine cycle metabolism. (D) Effects of methionine re-
striction and recovery on the methionine salvage pathway (MTA). (E) Effects of me-
thionine restriction and recovery on the transsulfuration pathway (cystathionine). (F)
Response of histone methylation to methionine restriction and recovery. Integrated in-
tensities are normalized to total H3 and fold change was calculated. All error bars are
computed from the SEM (n=3).
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Together these findings indicate that the methionine cycle is reversible even
when the remainder of global metabolism is altered. Furthermore, these results
show that the recovery of the levels of the metabolites in the methionine cycle
is sufficient to restore the levels of histone methylation.
3.3.4 Methionine Restriction Decreases H3K4me3 Signature
Peaks and Alters Gene Expression
Although results from immunoblotting identified global alterations in histone
methylation after methionine restriction, it remained unclear whether methion-
ine metabolism affected specific marks on the genome to mediate gene expres-
sion. We therefore sought to determine the precise location H3K4me3 on the
genome using chromatin immunoprecipation with sequencing (ChIP-seq) and
the consequences on gene expression using RNA-sequencing (RNA-seq). The
sensitivity was first confirmed using serial titrations of H3K4me3 peptides (Fig-
ure 3.12A) and the specificity of the H3K4me3 antibody was tested with modi-
fied histone peptide array (Figure 3.12B, C) as suggested in the ENCODE guide-
lines (Bailey et al., 2013). From these results we conclude that the H3K4me3 anti-
body is sensitive and specific for H3K4me3. There was little off target reactivity
and binding was not significantly altered when H3K4me3 was present on H3
peptides with other post-translational modifications (except phosphorylation).
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Figure 3.12: H3K4me3 Antibody Specificity
(A) Dot blot using H3K4me3 ChIP-seq antibody with unmodified and modified his-
tone peptides at varying concentrations. (B) H3K4me3 ChIP-seq antibody reactivity
ranked high to low for peptides with H3K4me3 plus up to three additional modifica-
tions on the same peptide. (C) H3K4me3 ChIP-seq antibody reactivity ranked high to
low for individual histone modifications. Inset shows ChIP-seq antibody reactivity for
H3K4me1/2/3, H3K9me1/2/3 and H3K27me1/2/3. ChIP-seq antibody reactivity was
measured using the Active Motif MODified Histone Peptide Array (cat #13001).
Cells were subjected to methionine restriction (-MET) or normal methionine
(+MET) conditions for 24 hours and cross-linked chromatin was collected for
H3K4me3 ChIP-seq analysis with total RNA collected for RNA-seq in parallel.
After peak calling (methods), replicate samples for the +MET and -MET condi-
tions cluster together suggesting the genome-wide profile of H3K4me3 marks
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are similar between replicates but vastly different between the conditions (Fig-
ure 3.13).
Figure 3.13: Replicates Cluster Together Based on MACS2 H3K4me3
Called Peaks
H3K4me3 ChIP-seq was performed in +MET and -MET conditions after 24 hours. Hi-
erarchical clustering was performed on replicates using peaks called from MACS2.
Next, we investigated the change in H3K4me3 peaks at the transcription
start site (TSS) of genes, since H3K4me3 at gene promoters has been associated
with gene transcription. Overall, we found that the H3K4me3 peaks around
the TSS are bimodal and decrease, on average, after methionine restriction (Fig-
ure 3.14A). In addition, H3K4me3 peaks decreased breadth after methionine
restriction (Figure 3.14B) but no significant change in H3K4me3 binding site
distribution around the TSS was observed (Figure 3.14C). Next, peak counts
were plotted for each chromosome showing H3K4me3 peak distribution across
the genome is relatively consistent (Figure 3.14D). Closer inspection of indi-
vidual chromosomes revealed that particular genomic regions are differentially
marked by H3K4me3.
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Figure 3.14: ChIP-seq Reveals Global Reductions in H3K4me3 at TSSs
(A) Change in H3K4me3 distribution around the TSS after 24 hours of methionine re-
striction. (B) Change in H3K4me3 TSS domain breadth after 24 hours of methionine
restriction. (C) Genome-wide binding site affinity from the TSS after methionine re-
striction. (D) Genome-wide distribution of H3K4me3 peaks in +MET (red) and -MET
(blue) conditions with an enlargement of chromosome 17.
To determine those H3K4me3 peaks that were lost or gained in response to
methionine restriction, peaks from both replicates in each condition were used
to make a consensus peak set containing all peaks in both +MET or -MET (see
Appendix B). This method removed peaks that were only present in one repli-
cate. Overall, a total of 27,235 peaks were identified (Figure 3.15A). Out of all
the peaks identified, most peaks, not surprisingly, were found in introns (Fig-
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ure 3.15B), since introns make up 37% of the human genome. Taking the distri-
bution of genomic features into consideration, H3K4me3 peaks were enriched
at the beginning of genes at the promoter and 5’UTR (Figure 3.15C). Finally,
we investigated where peaks were lost or gained in response to methionine de-
privation. A total of 6,457 peaks were lost after methionine restriction and 184
peaks were gained. Of these, most peaks were lost at promoters (33%) (Fig-
ure 3.15D). Those peaks that appeared after methionine restriction were found
at intergenic regions (57%) (Figure 3.15E).
For each peak, the closest gene was identified using the Homer Software
Suite (see Appendix B). No significant gene set enrichment was observed for
genes closest to H3K4me3 peaks gained after methionine restriction. Note
though most peaks gained after methionine restriction occur in the intergenic
regions. For peaks lost during methionine restriction in HCT116 cells we fo-
cused on loss at the promoter regions. Gene enrichment analysis confirmed
promoters of genes that lost H3K4me3 after methionine restriction in our study
overlapped well with known genes with H3K4me3 present at the promoter in
HCT116 cells from ENCODE (adjusted p = 2.5x10-38). In addition, many peaks
were lost at genes involved in Wnt signaling, GTPase activity, and CTCF bind-
ing.
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Figure 3.15: Genomic Distribution of H3K4me3 in Response to Methio-
nine Restriction
(A) H3K4me3 peaks called by MACS2 before and after methionine restriction. (B) Per-
cent of all H3K4me3 peaks found in each genomic region. (C) Enrichment of H3K4me3
peaks in each genomic region. (D) Percent of H3K4me3 peaks lost after methionine
restriction found in each genomic region. (E) Percent of H3K4me3 peaks gained after
methionine restriction found in each genomic region.
Since promoter H3K4me3 is a signature for active transcription we further
investigated how decreased H3K4me3 at promoters affects gene transcription.
To this end we performed RNA-seq (Figure 3.16) under methionine-restricted
conditions in HCT116 cells and compared these results to our ChIP-seq analysis.
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Figure 3.16: Global Effects on Transcription After Methionine Restric-
tion
RNA-seq was performed in +MET and -MET after 24 hours in parallel with ChIP-seq
experiments. (A) Hierarchical cluster was performed on replicates using normalized
counts from DESeq2. (B) RNA-seq identifies differentially expressed (FDR < 0.05) genes
(red) after methionine restriction. (C) Pathway enrichment analysis for genes signifi-
cantly up-regulated after methionine restriction. (D) Pathway enrichment analysis for
genes significantly down regulated after methionine restriction. Percent overlap is cal-
culated as the number of hits divided by the number of genes in the list. The number of
hits out of total number of genes in the list is shown in each bar. The corrected p-value
is shown to the right of each bar.
Hierarchical clustering revealed strong correlation between replicate experi-
ments (Figure 3.16A). Using DESeq2, 5,375 significantly differentially expressed
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genes were identified (Figure 3.16B). Genes with significantly up-regulated ex-
pression were enriched for pathways involved in angiogenesis, Interferon pro-
duction, NF-KB signaling and Rho GTPase activity (Figure 3.16C). Genes with
significantly decreased expression were enriched for pathways involved in the
mitotic cell cycle and DNA replication (Figure 3.16D).
Interestingly, we found that colorectal cancer (CRC)-associated genes were
enriched for loss of H3K4me3 at promoters with resulting decreased expression
(p = 0.02, Fisher’s Exact Test). Notably the cancer-associated genes AKT1, MYC,
and MAPK, among others are responsive to decreases in promoter H3K4me3
(Figure 3.17A). In addition, CRC genes that have significant decreases in gene
expression also show significant decreases in H3K4me3 over the promoter re-
gion when compared to genome wide loss of H3K4me3 (Figure 3.17B). Overall,
these results suggest that nutrient status, has a dramatic effect on the chromatin
state and gene regulation in cells with likely effects on pathophysiological out-
comes.
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Figure 3.17: Methionine Restriction Decreases H3K4me3 at Colon Can-
cer Genes and Alters Gene Expression
(A) Distribution of H3K4me3 at the TSS of colon cancer genes with significantly reduced
expression after methionine restriction compared to the average genome distribution.
(B) Changes in H3K4me3 ChIP-seq signal with corresponding changes in gene expres-
sion form RNA-seq for colon cancer genes.
To further evaluate specific physiological consequences of this mechanism,
we identified a network of enzymes involved in one carbon metabolism that
show decreased H3K4me3 with concomitant decreases in expression (Fig-
ure 3.18) suggesting a feedback mechanism that decreases consumption of SAM
by alternate pathways and an attempt to maintain H3K4me3 by regulation of
JARID1B (KDM5B), H3K4me3 demethylase that is deregulated in cancer (Ya-
mane et al., 2007). MAT2A, the predominant SAM producer in these cells,
is significantly up-regulated under methionine restricted conditions, whereas,
AHCY, responsible for the conversion of SAH to homocysteine is significantly
down regulated (Figure 3.18B). In addition, many of the enzymes involved in
pathways connected to methionine metabolism are downregulated (methionine
salvage, folate cycle).
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Figure 3.18: Methionine Restriction Decreases H3K4me3 at One Carbon
Genes and Alters Gene Expression
(A) Changes in H3K4me3 ChIP-seq signal with corresponding changes in gene expres-
sion form RNA-seq for methionine cycle genes. (B) Normalized expression of methio-
nine cycle genes before and after methionine restriction. (C) Schematic highlighting
enzymes (from A) in red with decreased H3K4me3 and gene expression essential in
one carbon metabolism and related pathways.
This finding is indicative of a signal transduction mechanism by which
alterations in H3K4me3 directly feedback to one carbon metabolism and
methylation-related enzymes to maintain physiological homeostasis.
69
3.3.5 Methionine Cycle Alterations Can Be Sustained by Diet
In Vivo
We next questioned whether changes in methionine can occur through and are
maintained in response to alterations in nutrient availability in a longer-term
physiological setting. We considered an analysis of the effects of methion-
ine restriction in vivo at a concentration that has been shown to have health-
promoting effects (Ables et al., 2012). Seven-week-old C57Bl6 mice were ran-
domized into two groups and one arm was fed a standard diet consisting of
0.84% (w/w) methionine and the other a methionine-restricted (MR) diet con-
sisting of seven times less methionine (0.12%, w/w) (Figure 3.19).
Figure 3.19: Methionine Restriction in Mice
Mice were fed a control or methionine restricted (MR) diet for 12 weeks. Representative
liver histology from each group is shown at 40x with hematoxylin and eosin (H&E)
staining.
We first confirmed that the MR diet specifically decreased serum methionine
levels compared to the levels of all other amino acids (Figure 3.20). In addition
to significantly reduced methionine, a significant increase in serine levels was
also observed mirroring the effects in vitro.
70
Figure 3.20: Change in Serum Amino Acid Levels After MR in Mice
Fold change of serum amino acids in mice fed control compared with methionine re-
stricted (MR) diet, measured by LC-MS (*p< 0.001).
At twelve weeks, mice were sacrificed and no gross phenotypic alterations
were observed as measured by liver histology and as previously described
(Ables et al., 2012) (Figure 3.19). An examination of the metabolite profile in
fasting serum and liver by carrying out unsupervised hierarchical clustering re-
vealed global alterations in metabolism in liver and plasma (Figure 3.21A) with
a pathway analysis revealing that cysteine and methionine metabolites were
predominantly altered in plasma (Figure 3.21B). Other amino acid metabolism
pathways to a lesser extent exhibited alterations. Inspection of metabolism in
liver exhibited sustained alterations in cysteine and methionine along with al-
terations in taurine metabolism and other amino acid metabolism pathways
(Figure 3.21C).
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Figure 3.21: MR in Mice Produces Distinct Metabolic Profile in Liver
and Plasma
(A) Global effects on metabolism in mouse serum and liver due to methionine restric-
tion (MR). (B) Pathway analysis on serum metabolites shows significantly different pro-
files between control and MR groups. (C) Pathway analysis on liver metabolites shows
significantly different profiles between control and MR groups.
Globally, an analysis of the quantile-quantile (Q-Q) plot showed skew-
ness towards more changes being observed in liver but with more significant
changes occurring in the serum (Figure 3.22A). These differences were further
exemplified by comparing correlations of metabolite levels between liver and
plasma (Figure 3.22B) with metabolites related to beta oxidation such as acylcar-
nitines, amino acid metabolism, and one carbon metabolism found to correlate
with the extent of methionine levels in the plasma (Figure 3.22C).
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Figure 3.22: Comparing the Metabolic Changes in Mice After MR in
Liver Versus Plasma
(A) Quantile-quantile plot of the differences in serum and liver. (B) Correlation analy-
sis of the metabolism in the liver and plasma. (C) Correlation analysis of methionine
levels and metabolites in plasma of MR animals. Significantly correlated metabolites
are identified. All statistical analyses performed were student’s t-tests, n=8, two-tailed,
α<0.05.
Together these findings indicate that the regions of the metabolic network
that are altered in response to sustained methionine-restriction in vivo are com-
parable to those aspects of the metabolic network that are dynamic in response
to acute methionine restriction in cells. Furthermore, the metabolic state of fast-
ing liver is different in the animals that were maintained on different diets for
the long term.
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3.3.6 Methionine Restriction In Vivo Sustains Altered Methio-
nine Cycle and Histone Methylation
Having demonstrated that cysteine and methionine metabolism exhibit sustain-
able alterations in mice, we then asked whether these changes led to differences
in the methionine cycle. In liver (Figure 3.23A), methionine concentrations ex-
hibited no significant changes suggesting that compensatory fluxes involving
its consumption or intake are occurring. These changes in fluxes resulted in
decreases in SAM, SAH, the SAM/SAH ratio, cystathionine, and methylth-
ioadenosine (MTA) and increases in the methyl donors dimethylglycine (DMG)
and betaine. However, in plasma (Figure 3.23B), methionine levels were main-
tained at lower levels in response to MR diet. In addition, cystathionine and
2-keto-4-methylthiobutyrate (KMTB) a component of the methionine salvage
pathway were also significantly decreased. Conversely, betaine and DMG each
exhibited increases suggestive of their possibility as plasma biomarkers. Me-
thionine cycle metabolites SAM and SAH did not show changes in plasma. This
observation was expected since cells are not thought to secrete these metabolites
at appreciable concentrations (Agrimi et al., 2004).
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Figure 3.23: Changes in Methionine Cycle Metabolism Are Sustained
by Diet in Vivo
(A) Methionine cycle metabolites in liver of mice fed Control or MR diet. (B) Methionine
cycle metabolites in plasma of mice fed Control or MR diet.
We next asked whether these sustained changes in the methionine cycle were
sufficient to induce changes in histone methylation. We observed decreases in
H3K4me3 in the methionine restricted liver (Figure 3.24A) that we quantified
(Figure 3.24B) indicating that the alterations in SAM and SAH levels observed
in the liver are sufficient to induce global changes in histone methylation.
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Figure 3.24: Decreased H3K4me3 In Liver or MID3 after MR
(A) Histone methylation (H3K4me3) in liver of MR mice. Integrated intensities were
normalized to total H3. (B) Quantitation of results in (A) from n=8 mice in each cohort.
P-value was obtained from a Student’s t-test with equal variance.
We found that SAM, the SAM/SAH ratio, cystathionine positively correlated
with H3K4me3 levels and methionine, betaine, and DMG negatively correlated
with H3K4me3 levels (Figure 3.25A, B). In plasma, the levels of methionine and
cystathionine were positively correlated and betaine and DMG were negatively
correlated (Figures 3.25C, D). Together these findings provide evidence that the
levels of SAM and SAM/SAH ratio in the liver are predictive of histone methy-
lation levels, that plasma metabolites in methionine cycle metabolism are pre-
dictive of histone methylation in liver and that these levels can be directly mod-
ulated by diet in mice.
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Figure 3.25: Correlation of Histone Methylation and Methionine Cycle
Metabolites
(A) Correlation of histone methylation and methionine cycle metabolites in the liver.
(B) Correlation of one carbon related metabolites and H3K4me3 in the plasma. (C) Cor-
relation of changes in histone methylation and methionine cycle metabolites in plasma.
(D) Correlation of other one carbon related metabolites and H3K4me3 in the plasma.
3.3.7 Humans Exhibit Variability in Methionine Levels
We next questioned whether variability in methionine metabolism exists in hu-
mans and how it can be regulated. Standard clinical parameters and a record
of dietary intake over four days was considered to reflect variations in habit-
ual diet as is standard practice in clinical nutrition (Levine et al., 2014) across
a cohort of healthy human subjects. Fasting serum was collected graciously by
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Anna Thalacker-Mercer and subjected to metabolomics performed by Xiaojing
Liu. Then an analysis was performed to determine the metabolic profiles ob-
served and the absolute concentration of metabolites . (Figure 3.26A, B).
Figure 3.26: Methionine and Metabolic Variation in Human Subjects
(A) Measurement of serum methionine and clinical and dietary variable in human sub-
jects. (B) Measurement of a metabolomics profile across the human cohort (N=38). Re-
sults of unsupervised clustering of a distance matrix for metabolites is shown. (C) Path-
ways that correspond to clusters observed in (B). Pathways were identified by consider-
ing the highest pathway impacts of all the metabolites contained in the specified cluster
denoted by the different colored boxes and nodes.
In addition to this, other analyses performed by Mahya Mehrmohamadi and
Lei Huang determined nutrient intake for each subject could be defined into
modules that classified subjects into discrete dietary behavior groups (such as
diets high in fruits and vegetables or carbohydrates)(Mentch et al., 2015).
We next measured the concentration of methionine along with a panel of
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amino acids in these subjects (Figure 3.27A). Strikingly, the concentration of me-
thionine exhibits substantial variation with values ranging from 3 to 30 µM (Fig-
ure 3.27B) with methionine exhibiting the largest variation (Figure 3.27C). This
variation in concentration is on the same order as that needed to induce changes
in histone methylation in cells and in mice. In addition, methionine in the serum
correlates with N,N,N-trimethyllysine and N-methylglycine (sarcosine), both of
which are methylated by the transfer of methyl groups from SAM, suggesting
that methionine levels in the serum are indicative of cellular methylation status
(Figure 3.27D, E).
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Figure 3.27: Methionine is the Most Variable Serum Amino Acid in a
Cohort of Healthy Subjects
(A) Absolute concentrations of amino acids in fasting serum were measured in 38 hu-
man subjects. (B) Absolute concentration of methionine in fasting serum. (C) Coeffi-
cients of variation of amino acids in fasting serum. (D) Correlation of methionine in
the serum with methylated serum metabolite N,N,N-trimethyllysine. (E) Correlation of
methionine in serum with methylated serum metabolite sarcosine.
Taken together, these findings demonstrate that the variability in methion-
ine concentration in humans is on the same scale as that needed to induce alter-
ations in histone methylation and that these differences correlate with changes
in diet and health status.
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3.4 Discussion
These findings together provide evidence for a dynamic regulatory mechanism
whereby the status of the methionine component of one carbon metabolism is
sensed by histones to determine the levels of methylation on critical residues
that mediate cellular epigenetic status. We first demonstrated that methion-
ine deprivation and subsequent depletion of SAM and SAH induce changes
in histone methylation. Furthermore, we tested and confirmed that these dy-
namics occurred in a manner consistent with a signal transduction mechanism.
Necessarily, we found that changes in histone methylation occurred at quanti-
tatively relevant concentrations of methionine. The kinetics of turnover of his-
tone methylation in response to SAM and SAH availability were found to occur
within hours and thus are much shorter than times corresponding to changes in
cell cycle progression or global stress responses that also affect histone methy-
lation. Importantly these dynamics were found to be reversible as the deple-
tion of histone methylation could be recovered upon restoration of methionine
availability even when the remainder of cellular metabolism was not recovered.
Each of these properties is consistent with a mechanism whereby the status of
key histone marks such as H3K4me3 that mediate chromatin structure, gene
expression, and cell identity directly sense the metabolic status of one carbon
metabolism.
In vivo, the dynamic response to methionine restriction further provided
support of such a mechanism since alterations in SAM and SAH could be sus-
tained in liver and these changes were sufficient to induce changes in histone
methylation. Interestingly, although this dietary intervention maintained re-
duced methionine levels in the serum, the levels in the liver were not altered
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suggesting that compensatory adaptations in methionine fluxes occurred, likely
through other remethylation pathways for example from Folate metabolism.
These metabolic adaptations likely serve to maintain other essential processes
involved in methionine metabolism possibly providing a basis for why methio-
nine restriction can be sustained in healthy animals even when changes in hi-
stone methylation are observed. Notably, methylation status and metabolism
were measured in fasting conditions where methionine restriction was shown
to alter histone methylation. This fasted condition we expect sets a lower bound
on the extent that the methionine cycle can be depleted with feeding contribut-
ing to increases in methionine levels. Given this observation, it is tempting to
speculate that feeding or a diurnal rhythm might regulate this effect, perhaps
raising methionine levels to recover depletions in histone methylation.
In humans, the variation of methionine in healthy individuals was found to
be largest across a panel of serum amino acids. Although these measurements
are by no means exhaustive of human population dynamics, concentrations in
many individuals were found to be far lower than the concentration required
to induce changes in methylation levels. Computational modeling of diet and
clinical variables performed by Mehrmohamadi & Huang (Mentch et al., 2015)
found that about thirty percent of the variation could be due to fundamental
clinical variables such as age, body composition, and gender, and about thirty
percent was modulated by diet. In the future the results from these models
could further be integrated with genomics data to specifically define the ge-
netic contributions as have been identified to associate with serum metabolite
levels (Suhre et al., 2011). Nevertheless it is tempting to speculate that basic di-
etary factors such as vegetable and fat intake could mediate human epigenetics
through modulation of methionine metabolism.
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3.4.1 One Carbon Metabolism as a Metabolic Signal Transduc-
tion Mechanism
Cellular decision-making occurs through signal transduction that utilizes post-
translation modifications. For example, protein kinases establish networks of
protein phosphorylation with multiple layers of nonlinear regulation that con-
trol almost all aspects of physiology. Despite the ubiquitous importance of hi-
stone and other macromolecular methylation, relatively little is known about
how methylation is regulated. In contrast to protein kinases where the substrate,
ATP, is in vast excess, the concentrations of SAM or SAH are on the order of the
kinetic parameters that determine enzyme activity. Thus much of histone and
other methylation could be regulated in large part by the status of methionine
metabolism and one carbon cycle flux consistent with relatively few numbers
of methyltransferases compared to the over 500 protein kinases that exist. This
type of regulation by virtue of its biochemistry would have fundamentally dif-
ferent control properties and information capacity than that of protein kinase-
mediated signaling. This regulation is evident in the feedback control observed
in genes in one carbon metabolism whose expression and H3K4me3 signature is
modulated in response to a decrease in SAM and SAH levels, likely as a specific
mechanism to maintain homeostasis in one carbon metabolism. In particular,
enzymes important in regenerating methionine by utilizing SAM are some of
the most down regulated genes with loss of H3K4me3 at their promoters.
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3.4.2 Methionine Metabolism in Pathophysiology through Its
Modulation of Chromatin State
Numerous studies have documented a contribution of methionine metabolism
and its restriction to beneficial metabolic health including the extension of mam-
malian life span, the acquisition of resistance to diet-induced obesity, and the
therapeutic efficacy of ketogenic diets (Kraus et al., 2014; Malloy et al., 2006;
Orentreich et al., 1993; Pissios et al., 2013). In each of these cases, the biological
mechanisms contributing to these outcomes are largely unknown. Although al-
terations in methylation status are likely not accounting for all of these effects,
it is possibly if not likely that the alterations in gene expression of key genes
important for the relevant physiological effect in each of these cases. Indeed
chronic diseases including obesity, diabetes, and cancer often stem from the in-
ability of the organism to adapt to the demands of their nutritional load (Ho-
tamisligil, 2010; Laplante and Sabatini, 2012). These adaptations require signal
transduction mechanisms that integrate nutritional status to achieve the desired
physiological demand. There are numerous signal transduction pathways that
sense nutritional status and it is likely that the sensing of one carbon metabolism
by histones is one of these mechanisms. Interestingly, this mechanism affected
gene regulation of several cancer-promoting genes. Many cancers are vulner-
able to disruptions in one carbon metabolism (Locasale, 2013), and our results
demonstrate the necessity of methionine metabolism for the maintenance of hi-
stone methylation and the consequences for expression of oncogenic programs.
Thus it is tempting to speculate that some of the anti-tumor effects of targeting
one carbon metabolism may occur through changes in cancer epigenetics and
further studies could more deeply elaborate these mechanisms.
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3.5 Experimental Procedures
3.5.1 Methionine Restriction in Cell Culture
For methionine deprivation, RPMI 1640 lacking amino acids, glucose, and glu-
tamine was supplemented with Minimal Essential Media Non-Essential Amino
Acids (MEM NEAA), 5mM glucose, 2 µM glutamine, 10% FBS, 100 U/mL peni-
cillin, and 100 mg/mL streptomycin. Essential amino acids, except methionine,
were added back at the same concentrations found in MEM Amino Acids Solu-
tion for minus methionine (-MET) media. For plus methionine (+MET) media,
methionine was added to -MET media to a final concentration of 100µM. For
titration experiments, methionine was added at the respective concentrations to
the -MET media. Each additional amino acid dropout media was prepared in a
similar manner but with concentrations supplemented to the respective condi-
tion in the plus amino acid condition. At the start of each experiment, cells were
seeded at a density of 2.2 x 106 cells for 10cm plates for protein collection or 3 x
105 cells/well in a 6-well plate for metabolite collection and allowed to adhere
for 24 hours. After a 24 hour incubation, cells were washed once with PBS and
placed in respective media for 24 hours unless otherwise noted
3.5.2 Mouse Feeding and Tissue and Plasma Analysis
Seven week-old C57BL/6J mice were purchased from Jackson Laboratories (Bar
Harbor, ME) and housed in a conventional animal facility maintained at 202C,
5010% relative humidity and a 12 h light: 12 h dark light cycle. All animal pro-
cedures were approved by the Institutional Animal Care and Use Committee of
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the Orentreich Foundation for the Advancement of Science, Inc. (Permit Num-
ber: 0511MB). Food and water were provided ad libitum. Upon arrival, the mice
were acclimated for one week and fed Rodent Chow 5001 (Purina LabDiets) and
water ad libitum. After one week, the mice were randomized and fed either an
isocaloric 0.84% (w/w) methionine (control-fed; CF, N=8) diet or 0.12% (w/w)
methionine (methionine-restricted; MR, N=8) diet from Research Diets. After
12 weeks of feeding, mice were fasted for 4 hours at the beginning of the light
cycle to establish a physiological baseline and then sacrificed. Blood was col-
lected from the retro-orbital plexus and plasma was collected, flash frozen and
stored at -80C until analyzed. The liver was harvested, flash frozen and stored
at -80C until processed. Liver tissues samples were fixed in 10% formalin solu-
tion (Thermo Scientific) and paraffin embedded. Hematoxylin and eosin (H &
E) staining and imaging was carried out at Histowiz, high resolution slide scan-
ning was carried out using Leica SCN400 and image analysis was conducted
using Image-pro software (Media Cybernetics).
3.5.3 Immunoblotting
Samples were homogenized in Triton Extraction Buffer (TEB: 0.5% Triton X
100, 2mM phenylmethylsulfonyl fluoride (PMSF), 0.02% NaN3 in PBS) and
centrifuged at 2000rpm for 10 min at 4C. Pellets were resuspended in 0.2N
HCl and histones were acid extracted overnight at 4C. Histone extracts were
loaded onto 12% SDS-PAGE gels and transferred to polyvinylidene difluoride
(PVDF) membranes. Membranes were blocked in 5% dry milk in TBST and in-
cubated with anti-H3K4me3 (Millipore, cat #07-473) 1:2000, anti-H3K9me3 (Mil-
lipore, cat #05-1250) 1:2000, anti-H3K27me3 (Millipore, cat #05-1951) 1:10000,
86
or anti-H3 (Millipore, cat #07-690) 1:10000. Horseradish-peroxidase-conjugated
anti-rabbit (Rockland cat #611-7302) or anti-mouse (Rockland, cat #611-4302),
1:10,000, were used as secondary antibodies. Chemiluminescent signals were
detected with Clarity Western ECL Detection Kit (Bio-Rad) and imaged using a
ChemiDoc MP System (Bio-Rad). All western blots are normalized to the total
H3 signal before relative quantification was calculated.
3.5.4 Metabolite Extraction and LC-HRMS Analysis
For culture from adherent cells, the media was quickly aspirated and cells were
washed with cold PBS then placed on dry ice. Then, 1mL of extraction solvent
(80% methanol/water) cooled to -80C was added immediately to each well, and
the dishes were transferred to -80C for 15 min. Plates were removed and cells
were scraped into the extraction solvent on dry ice. For tissue, the sample was
homogenized in liquid nitrogen and then 5 to 10 mg was weighed in a new
Eppendorf tube. Ice-cold extraction solvent (250µL) was added to each tissue
sample and homogenized using a tissue homogenizer. The homogenate was in-
cubated on ice for 10 min. For plasma or serum, 20µL was transferred to a new
Eppendorf tube containing 80µL HPLC grade water. Next, 400µL of ice-cold
methanol was added to the sample for a final methanol concentration of 80%
(v/v). Samples were incubated on ice for 10 min. All metabolite extracts were
centrifuged at 20,000g at 4C for 10 min. Finally the solvent in each sample was
evaporated in a Speed Vacuum for metabolomics analysis. For polar metabolite
analysis, the cell extract was dissolved in 15µL water and 15µL methanol/ace-
tonitrile (1:1 v/v) (LC-MS optima grade, Thermo Scientific). Samples were cen-
trifuged at 20,000g for 10min at 4C and the supernatants were transferred to
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Liquid Chromatography (LC) vials. The injection volume for polar metabolite
analysis was 5µL.
3.5.5 Liquid Chromatography
An Xbridge amide column (100 x 2.1 mm i.d., 3.5 ?m; Waters) is employed on a
Dionex (Ultimate 3000 UHPLC) for compound separation at room temperature.
The mobile phase A is 20 mM ammonium acetate and 15 mM ammonium hy-
droxide in water with 3% acetonitrile, pH 9.0 and mobile phase B is acetonitrile.
Linear gradient as follows: 0 min, 85% B; 1.5 min, 85% B, 5.5 min, 35% B; 10min,
35% B, 10.5 min, 35% B, 14.5 min, 35% B, 15 min, 85% B, and 20 min, 85% B. The
flow rate was 0.15 ml/min from 0 to 10 min and 15 to 20 min, and 0.3 ml/min
from 10.5 to 14.5 min. All solvents are LC-MS grade and purchased from Fisher
Scientific.
3.5.6 Mass Spectrometry
The Q Exactive MS (Thermo Scientific) is equipped with a heated electrospray
ionization probe (HESI), and the relevant parameters are as listed: evaporation
temperature, 120 C; sheath gas, 30; auxiliary gas, 10; sweep gas, 3; spray voltage,
3.6 kV for positive mode and 2.5 kV for negative mode. Capillary temperature
was set at 320C, and S-lens was 55. A full scan range from 60 to 900 (m/z) was
used. The resolution was set at 70 000. The maximum injection time was 200
ms. Automated gain control (AGC) was targeted at 3,000,000 ions.
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3.5.7 Metabolomics and Data Analysis
Raw data collected from LC-Q Exactive MS is processed on Sieve 2.0 (Thermo
Scientific). Peak alignment and detection are performed according to the pro-
tocol described by Thermo Scientific. For a targeted metabolite analysis, the
method “peak alignment and frame extraction” is applied. An input file of the-
oretical m/z and detected retention time of 263 known metabolites is used for
targeted metabolites analysis with data collected in positive mode, while a sep-
arate input file of 197 metabolites is used for negative mode. M/Z width is set at
10 ppm. The output file including detected m/z and relative intensity in differ-
ent samples is obtained after data processing. Dot plots and other quantitation
and statistics were calculated and visualized with the Graphpad prism software
package.
3.5.8 RNA Sequencing
Total RNA was extracted using the PARIS kit (Life Technologies, cat #AM1921),
polyA selected before library generation, and prepared according to a standard
protocol provided by Illumina by the Weill Cornell Medical College Epige-
nomics Core. Samples were pooled into one lane on the Illumina HiSEQ2500
and sequenced. Reads were mapped to the reference genome (hg19) using
TopHat2.0.7 in the Galaxy software suite (https://usegalaxy.org). For the analy-
sis, we generated a counts table from accepted hits bam files using HTseq ((An-
ders et al., 2015)) with the following parameters: htseq-count -f bam -s yes [input
bam] [hg19genes.gtf]. Differential expression was calculated from the counts
table using the edgeR package in R (Nikolayeva and Robinson, 2014; Robinson
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et al., 2010) and DEseq2 (Love et al., 2014).
3.5.9 Chromatin Immunoprecipation and Sequencing
HCT116 cells were cultured in 15cm plates resulting in 3x107 cells at 80% con-
fluency. Cells were cross-linked for 5 minutes at room temperature by addition
of 1% formaldehyde to the cell culture media. The reaction was quenched for 5
minutes by the addition of 2.5M glycine. Cells were collected and lysed in FA
buffer (50mM HEPES/KOH pH 7.5, 1mM EDTA, 1% Triton X-100, 0.1% sodium
deoxycholate, 1M NaCl) with protease inhibitors. Cross-linked chromatin was
resuspended in LB3 (10mM Tris-HCl, pH 8.0, 200mM NaCl, 1mM EDTA, pH 8.0,
0.5mM EGTA, pH 8.0, 0.1% Sodium deoxycholate, 0.5% N-lauroylsarcosine) and
samples were sheared using the Covaris M2 ultrasonicator (Covaris) . Each IP
was performed as previously described, (Ercan et al., 2007; Landt et al., 2012)
(Ercan et al., 2007; Landt et al., 2012) using 1.5x107 cells and the Millipore
ChIPAb+ H3K4me3 antibody (cat #17-614, lot #2196044) with Protein A Agarose
beads (Millipore, cat #16-125, lot #2444123). Libraries were made and pooled ac-
cording to Illumina instructions, then sequenced on an Illumina HiSEQ 2500
Rapid Run sequencer. Reads were mapped to the reference genome (hg19)
using Bowtie2.2.4. H3K4me3 ChIP peaks were called using MACS2.08 with
the broad setting. Alignment and peak calling were performed on the Galaxy
platform (Blankenberg et al., 2010; Giardine et al., 2005; Goecks et al., 2010).
H3K4me3 distribution was visualized using the ngsplot package (Shen et al.,
2014) and ChIPseeker in R (Yu et al., 2015).
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3.5.10 Analysis of ChIP-seq Results for Differentially Bound
Chromosome Regions
We used the R package ”DiffBind” (Stark and Brown, 2011) to find regions with
a significant difference in H3K4me3 between the minus-Methionine and the
plus-Methionine conditions. In summary, peaks were first called by MACS2
(see Appendix B) to generate a consensus peak-set which we defined as a set of
peaks called in at least 2 samples. Then using the original read files, we gen-
erated the counts table including the number of reads corresponding to each
consensus peak in each sample. Finally using edgeR and DESeq2 we performed
differential binding analysis on all of the consensus peaks and reported the sig-
nificantly differentially bound regions (FDR¡0.1). Finally, the ”quantsmooth”
package in R (Oosting et al., 2014; Ross-Innes et al., 2012) was used to overlay
counts onto the human chromosomal ideograms.
3.5.11 Clinical Nutrition Studies
A four-day diet record was collected according to previous standards of record-
ing diet to reflect habitual behaviors as has been previously described (Levine
et al., 2014). Surveys were converted into nutritional variables according to pre-
viously described procedures using standard software (Levine et al., 2014). Nu-
trition data system for research (NDSR) dietary analysis software (University
of Minnesota), a comprehensive food and nutrient database, was used to de-
termine the average macro- and micronutrients consumed over the four-day
period as previously described (Thalacker-Mercer et al., 2009). Before serum
was collected, each subject was subjected to overnight fasting. Metabolites
91
from serum were extracted using a previously described protocol (Shestov et al.,
2014) (Shestov et al., 2014). All additional clinical variables were recorded ac-
cording to previously described methods (Thalacker-Mercer et al., 2013, 2009).
The computational model of the factors contributing to methionine concentra-
tion variation is described in detail later.
3.5.12 Statistical Analysis
Error bars represent standard error of the measurement (SEM). Significance re-
ported are results from Student’s t-test unless otherwise noted.
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CHAPTER 4
CONCLUSIONS AND FUTURE DIRECTIONS
4.1 Conclusions
The previous experiments show the link between decreased methionine avail-
ability, decreased SAM pools and decreased H3K4me3. Inspection of the loss
H3K4me3 and subsequent changes in gene expression suggests some gene net-
works may be directly affected by methionine deprivation. However, more
work needs to be done to explore this relationship.
4.2 Future Directions
4.2.1 Quantitative ChIP-seq and Peak Parameterization
First, standard ChIP-seq experiments are flawed at several levels due to ex-
perimental limitations. It would be useful to characterize H3K4me3 peaks in
more detail with high confidence. Traditionally, ChIP-seq relies on peaks being
present or absent. With increased complexity in experimental set ups like time
courses, or conditions where the loss of signal is expected problems can arise
during the experiment and analysis. To address these concerns, several methods
have been suggested in order to quantitatively assess the differences in ChIP-seq
signal. Methods such as those presented in Orlando et al. (2014) should be used
for quantitative analysis. These methods employ a spike in strategy that allows
for empirical normalization during alignment and can eliminate problems that
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arise from differences in sample preparation and sequencing so true differences
between the ChIP-seq signal can be determined. Where standard methods have
restricted the analysis, using these quantitative methods will allow us to deter-
mine the true differences between H3K4me3 distribution in normal methionine
and methionine restricted conditions.
It has already been shown the breadth of H3K4me3 peaks is an important
factor in tissue specific gene expression (Benayoun et al., 2014; Chen et al., 2015).
This could be expanded upon, and ChIP-seq peak signals could be parameter-
ized (Figure 4.1).
Figure 4.1: Quantitative Peak Parameters
Using quantitative ChIP-seq methodologies, peak parameters such as width, height,
and area could be used to determine the absolute differences after methionine restric-
tion.
Not only could breadth (or width) be investigated, but the impact on
changes in peak height, area, and others could be investigated. This would
be especially interesting in the case of methionine restriction since we observe
an overall decrease in H3K4me3 peak signal across the genome. If we could fur-
ther quantitatively analyze the changes in peak height and area, we may gain
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a better insight into how these changes affect gene transcription and cellular
identity.
4.2.2 Chromatin Dynamics in Response to Methionine Restric-
tion
So far I have investigated the dynamics of H3K4me3 in response to methion-
ine restriction at the global level. However, it would be interesting to observe
the changes of H3K4me3 at each genomic region and determine how this cor-
relates with gene expression. It is possible the genomic context and location of
H3K4me3 will play a significant role in how fast a reduction is observed.
To characterize the dynamic response to methionine restriction on histone
methylation and the effects on gene transcription at high resolution, ChIP-seq
and RNA-seq will need to be performed during a methionine restriction time
course. Since decreases in H3K4me3 are observed after only 4 hours, it would
be informative to include 0, 2, 4 hour time points in addition to later–6, 8, 12,
24 hour–time points. To analyze the data, quantitative ChIP-seq should be
performed using a spike-in strategy to determine the absolute differences in
H3K4me3 peaks after methionine restriction.
In addition to this experiment, a parallel rescue experiment could be per-
formed to assess how specifically H3K4me3 is recovered after methionine res-
cue for 24 hours. At least one additional time point at 48 hours (24 hours after
methionine is added back to cells that were methionine restricted for 24 hours)
would be necessary to understand what regions of the genome, or which spe-
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cific gene sets are recovered. Additional time points after the addition of me-
thionine could also reveal at what rate the recovery takes place.
To analyze the data, the rate of H3K4me3 loss at each gene could be calcu-
lated and each gene categorized by how fast it is affected by methionine restric-
tion. This information could give rise to a network of early and late genes that
are methionine restriction sensitive.
4.2.3 Changes in H3K4me3 in Response to Methionine Restric-
tion and Effects on Splicing
Alternative splicing is a mechanism that allows cells to expand the diversity
of the proteome. Affecting nearly 95% of genes (Pan et al., 2008), alternative
splicing is important in cellular identity and differentiation (Barash et al., 2010).
Previous studies have identified H3K4me3 as an important player in recruit-
ing splicing machinery and directing alternative splicing in normal and cancer
cells (Sims et al., 2007; Podlaha et al., 2014; Curado et al., 2015). With this in
mind, it will be important to determine if decreases observed in H3K4me3 after
methionine restriction alter the distribution of alternatively spliced transcripts.
To perform these experiments, additional ChIP-seq and deep RNA-seq must
be performed to identify alternatively spliced transcripts upon methionine re-
striction. Alternatively spliced transcripts identified can then be cross refer-
enced to changes observed in H3K4me3 at these genes. If a relationship exists,
we hypothesize changes in H3K4me3 at these genes will occur. These changes
in H3K4me3 peaks should be further characterized to determine if decreases
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or complete loss of H3K4me3 signal are potentially responsible for alternative
splicing. Other experiments would need to be performed to confirm any de-
creases in H3K4me3 peaks at alternatively spliced genes reduce binding of the
splicing machinery. For these experiments, ChIP-seq utilizing antibodies for
subunits of the splicing machinery will be necessary.
4.2.4 Impact on Other Methylation Events
This thesis only investigates a few histone methylation events and focuses on
H3K4me3 since it had the most dramatic decrease in methylation after methio-
nine restriction. However, with the array of histone methylation sites and pos-
sibility of mono-, di-, and tri-methylation there is still much to investigate. In
addition to histone methylation, DNA methylation also plays a role in regulat-
ing gene expression (Bird, 2002). With recent work highlighting the dynamic
characteristic of DNA methylation (Smith and Meissner, 2013), it should be in-
vestigated further. In addition, decreased folate, the other half of the one carbon
metabolic cycle, has been linked to decreased DNA methylation (Crider et al.,
2012). Therefore, it is not far reaching to suspect DNA methylation might be
altered as well.
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APPENDIX A
CODE FOR RNA-SEQ ANALYSIS
A.1 Generating Counts Table Using HTSeq
Counts tables were generated using HTSeq-0.6.1 for each sample 3/20/2016.
The gene annotation gtf file (hg19 genes.gtf) was downloaded from Galaxy on
10/4/2015. It was originally uploaded to the server from Genomes 10/1/2012.
htseq−count − f bam
TopHat/0hr1\RNA\TopHat\Accepted\Hits . bam
˜/ hg19 genes . g t f > Counts/0hr1 . htseqcounts . csv
htseq−count − f bam
TopHat/0hr2\RNA\TopHat\Accepted\Hits . bam
˜/ hg19 genes . g t f > Counts/0hr2 . htseqcounts . csv
htseq−count − f bam
TopHat/24 hr1\RNA\TopHat\Accepted\Hits . bam
˜/ hg19 genes . g t f > Counts/24 hr1 . htseqcounts . csv
htseq−count − f bam
TopHat/24 hr2\RNA\TopHat\Accepted\Hits . bam
˜/ hg19 genes . g t f > Counts/24 hr2 . htseqcounts . csv
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A.2 RNA Differential Expression Analysis Using DESeq
# i n s t a l l and l o a d DESeq
b i o c L i t e ( ”DESeq” )
l i b r a r y ( DESeq )
countTable<− read . table ( ”CountsfromHTseq . t x t ” ,
header=TRUE,
row . names=1 ,
sep=” , ” )
# remove rows t h a t a r e where sum i s <5 f o r a l l g en e s
x<−rowSums ( countTable )>5
countTable<−countTable [ x , ]
data<−countTable
# c r e a t e a new DESeq o b j e c t
cds=newCountDataSet ( data ,
c ( ”pMET” , ”pMET” , ”mMET” , ”mMET” ) )
#New DESeq P i p e l i n e ( s i m i l a r t o EdgeR )
# e s t im a t e e f f e c t i v e l i b r a r y s i z e
cds= e s t i m a t e S i z e F a c t o r s ( cds )
s i z e F a c t o r s ( cds )
# v i s u a l i z e d no rma l i z e d c oun t s
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head ( counts ( cds , normalized=TRUE) )
# Es t ima t e d i s p e r s i o n ( v a r i a n c e be tween samp l e s )
cds=es t imateDispers ions ( cds )
# D e s c r i p t o r s o f d i s p e r s i o n f u n c t i o n
s t r ( f i t I n f o ( cds ) )
# p l o t d i s p e r s i o n
plotDispEsts ( cds )
# Ca l l i n g d i f f e r e n t i a l e x p r e s s i o n
re s=nbinomTest ( cds , ”pMET” , ”mMET” )
head ( re s )
# p l o t log2FC vs mean no rma l i z e d c oun t s h i g h l i g h t i n g
↪→ s i g n i f i c a n t <10$\%$ FDR
plotMA ( res , col= i f e l s e ( r es $ padj >0.05 ,
” black ” ,
” f i r e b r i c k 1 ” ) ,
cex . axis =2)
# h i s t og r am o f pValues
h i s t ( r es $pval , breaks =100 ,
col=” skyblue ” ,
border=” s l a t e b l u e ” ,
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main=”” )
# f i l t e r s i g n i f i c a n t l y e x p r e s s e d gene s
r e s S i g =re s [ re s $ padj <0 .1 , ]
head ( r e s S i g )
# view most s t r o n g l y down r e g u l a t e d g ene s
head ( r e s S i g [ order ( r e s S i g $ foldChange ) , − r e s S i g $baseMean ] )
# view most s t r o n g l y up r e g u l a t e d g ene s
head ( r e s S i g [ order (− r e s S i g $ foldChange , − r e s S i g $baseMean ) , ] )
# wr i t e r e s u l t s t a b l e wi th d i f f e r e n t i a l e x p r e s s i o n
↪→ c a l c u l a t i o n s
write . table ( res , f i l e =”DESeqDiffExpChIP−seqResul tsCutof f<5
↪→ fromHTseqCounts . t x t ” )
# heatmap
cdsBlind = es t imateDispers ions ( cds , method = ” bl ind ” )
vsdFull = v a r i a n c e S t a b i l i z i n g T r a n s f o r m a t i o n ( cds )
l i b r a r y ( ”RColorBrewer” )
l i b r a r y ( ” ggplot2 ” )
s e l e c t = order ( rowMeans ( counts ( cds ) ) ,
decreas ing=TRUE) [ 1 : 2 5 ]
hmcol = colorRampPalette ( brewer . pal ( 9 , ”GnBu” ) ) ( 2 5 )
113
heatmap ( exprs ( vsdFull ) [ s e l e c t , ] ,
col = hmcol , t r a c e =”none” ,
margin=c ( 1 0 , 6 ) )
##########################
#Gene Anno ta t i ons
# ########################
#Load t h e human d a t a b a s e
b i o c L i t e ( ” org . Hs . eg . db” )
l i b r a r y ( org . Hs . eg . db )
#Returns what IDs can be c o nv e r t e d
keytypes ( org . Hs . eg . db )
#make v a r i a b l e f o r c u r r e n t IDs ( f b i d s ) and what t o r e t u rn
↪→ ( c o l s )
f b i d s<−rownames ( data )
c o l s<−”SYMBOL”
# s e a r c h Hs d a t a b a s e f o r k e y s ( c u r r e n t IDs ) , r e t u rn SYMBOLS,
↪→ k ey s I have a r e ENSEMBL gene s
annots<−s e l e c t ( org . Hs . eg . db , keys=fbids ,
columns=c ( ”SYMBOL” ) ,
keytype=”ENSEMBL” )
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write . table ( annots ,
f i l e =”FromENSEMBLtoSYMBOL . t x t ” ,
sep=” , ” )
# I n c l u d e Gene Symbols in da t a t a b l e
annotsTable<− cbind (ENSEMBL=rownames ( as . data . frame ( data ) ,
as . data . frame ( data ) ) )
newTable = merge ( data ,
annots ,
by . x=”ENSEMBL” )
write . table ( newTable ,
f i l e =” annotatedOutputFi l ter<5Reads . t x t ” , sep=”\ t ” )
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APPENDIX B
CODE FOR CHIP-SEQ ANALYSIS
B.1 MACS2 - Calling H3K4me3 Peaks
MACS2 was used to call H3K4me3 peaks using bam files aligned to hg19. Input
controls for each sample were used to determine background.
MACS2 c a l l p e a k
− t ˜/ Galaxy176 −\[0−3K Sorted BAM \ ] . bam
−c ˜/ Galaxy169 −[0−3 I Sorted BAM ] . bam
−n pMET2
− f BAM
−g hs
−q 0 . 0 5
−B
MACS2 c a l l p e a k
− t ˜/ Galaxy177 −\[24−3K Sorted BAM \ ] . bam
−c ˜/ Galaxy178 −[24−3 I Sorted BAM \ ] . bam
−n mMET2
− f BAM
−g hs
116
−q 0 . 0 5
−B
MACS2 c a l l p e a k
− t /˜/ Galaxy175 −\[24−2K Sorted BAM \ ] . bam
−c ˜/ Galaxy168 −\[24−2 I Sorted BAM \ ] . bam
−n mMET1
− f BAM
−g hs
−q 0 . 0 5
−B
MACS2 c a l l p e a k
− t ˜/0−2 K Filtered SAM . bam
−c ˜/ Galaxy129 −\[0−2 I Sorted BAM \ ] . bam
−n pMET1
− f BAM
−g hs
−q 0 . 0 5
−B
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B.2 Consensus Peak Set for Downstream Analysis
Using R, replicate peaks called by MACS2 are combined by keeping peaks in
replicate 1 and replicate 2 for each condition. Then a consensus peak set is gen-
erated by combining peaks found in +MET or peaks found in -MET. A sample
input file is generated that includes the paths to MACS2 peak files, MACS2
summit files, and bam files for each sample. This file is used to produce the
final results.
l i b r a r y ( GenomicRanges )
l i b r a r y ( ShortRead )
l i b r a r y ( r t r a c k l a y e r )
#Load i n f o f i l e f o r s amp l e s
setwd ( ” ˜ / working d i r e c t o r y ” )
samples<−read . csv ( ”samples . csv ” )
####################################################
# FUNCTION mankeconsensus
# make c ons en su s peak s e t
# append h e i gh t , width , a r e a me tada t a columns
####################################################
118
makeconsensus <− function ( P e a k F i l e L i s t ) {
for ( i in 1 : length ( P e a k F i l e L i s t ) ) {
mcols ( P e a k F i l e L i s t [ [ i ] ] ) <− NULL
i f ( i == 1) {
ToMerge <− P e a k F i l e L i s t [ [ i ] ]
} e lse {
ToMerge <− c ( ToMerge , P e a k F i l e L i s t [ [ i ] ] )
}
}
NonOverlappingSet <− reduce ( ToMerge ) # removes
↪→ o v e r l a p p i n g p e a k s
# coun t s o v e r l a p s be tween NonOver lapp ingSet and P e a k f i l e
↪→ us ing l a p p l y
Temp <− do . c a l l ( cbind , lapply ( P e a k F i l e L i s t , function ( x )
↪→ countOverlaps ( NonOverlappingSet , x ) ) )
Temp[Temp > 1] <− 1 # p e a k s with more than 1 o v e r l a p s e t
↪→ t o 1
# add temp t o NonOver lapp ingSet a s me tada t a (1= p r e s e n t in
↪→ da t a s e t , 0=not p r e s e n t )
elementMetadata ( NonOverlappingSet ) <− Temp
return ( NonOverlappingSet )
}
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################################
# FUNCTION coun t a r e a
# Read in bam f i l e s and use bed
# r e g i o n s t o count t h e # o f t a g s in e a ch
# peak . Output peak ’ a r ea ’
# ###############################
countarea<−function ( bamfile , b e d f i l e ) {
reads<−readGAlignments ( bamfi le )
regions<−b e d f i l e
reads<−as ( reads , ”GRanges” )
regions<−as ( regions , ”GRanges” )
area<−countOverlaps ( regions , reads , ignore . s trand=TRUE)
area<−as . data . frame ( area )
return ( area )
}
################################
# COMPARE 0−24HR
################################
l i b r a r y ( GenomicRanges )
#Load macs2 output f i l e s
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myFiles<−as . vector ( samples$peak . f i l e )
myData <− lapply ( myFiles , read . delim , skip =26)
# Cr e a t e names f o r e a ch d a t a s e t in myData
n<−samples $name
names ( myData )<−n
###########################
# MERGE r e p l i c a t e p e a k s f i l e s
# ##########################
myData<−lapply ( myData , GRanges )
merge<−mergeByOverlaps ( myData [ [ 1 ] ] , myData [ [ 2 ] ] )
# have t o do t h i s funky t h ing in o r d e r t o make DataFrame (
↪→ f rom GenomicRanges ) t o a c t u a l d a t a f r ame
x1<−as . data . frame ( GRanges ( merge$myData . . 1 . . ) , row . names =
↪→ NULL, opt iona l=FALSE)
x2<−as . data . frame ( GRanges ( merge$myData . . 2 . . ) , row . names=
↪→ NULL, opt iona l=FALSE)
myData [ [ ( length ( myData ) +1) ] ]<−cbind ( x1 , x2 )
# name new column in da t a . f r ame f o r merge
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names ( myData ) [ length ( myData ) ]<−”merge0hr”
merge<−mergeByOverlaps ( myData [ [ 3 ] ] , myData [ [ 4 ] ] )
# have t o do t h i s funky t h ing in o r d e r t o make DataFrame (
↪→ f rom GenomicRanges ) t o a c t u a l d a t a f r ame
x1<−as . data . frame ( GRanges ( merge$myData . . 3 . . ) , row . names =
↪→ NULL, opt iona l=FALSE)
x2<−as . data . frame ( GRanges ( merge$myData . . 4 . . ) , row . names=
↪→ NULL, opt iona l=FALSE)
myData [ [ ( length ( myData ) +1) ] ]<−cbind ( x1 , x2 )
# name new column in da t a . f r ame f o r merge
names ( myData ) [ length ( myData ) ]<−”merge24hr”
myData<−myData [ c (−1 ,−2 ,−3 ,−4) ]
names ( myData [ [ 1 ] ] )<−c ( ” chr ” , ” s t a r t ” , ”end” , ”width . 0 hr1 ” ,
↪→ ” strand . 0 hr1 ” , ” length . 0 hr1 ” , ”summit . 0 hr1 ” , ”
↪→ pileup . 0 hr1 ” , ” pval . 0 hr1 ” , ” f c . 0 hr1 ” , ” qval . 0 hr1 ” , ”
↪→ name . 0 hr1 ” , ” chr2 ” , ” s t a r t 2 ” , ”end2” , ”width . 0 hr2 ” ,
↪→ ” strand . 0 hr2 ” , ” length . 0 hr2 ” , ”summit . 0 hr2 ” , ” pi leup
↪→ . 0 hr2 ” , ” pval . 0 hr2 ” , ” f c . 0 hr2 ” , ” qval . 0 hr2 ” , ”name . 0
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↪→ hr2 ” )
names ( myData [ [ 2 ] ] )<−c ( ” chr ” , ” s t a r t ” , ”end” , ”width . 2 4 hr1 ”
↪→ , ” strand . 2 4 hr1 ” , ” length . 2 4 hr1 ” , ”summit . 2 4 hr1 ” , ”
↪→ pileup . 2 4 hr1 ” , ” pval . 2 4 hr1 ” , ” f c . 2 4 hr1 ” , ” qval . 2 4 hr1
↪→ ” , ”name . 2 4 hr1 ” , ” chr2 ” , ” s t a r t 2 ” , ”end2” , ”width . 2 4
↪→ hr2 ” , ” strand . 2 4 hr2 ” , ” length . 2 4 hr2 ” , ”summit . 2 4 hr2 ”
↪→ , ” pi leup . 2 4 hr2 ” , ” pval . 2 4 hr2 ” , ” f c . 2 4 hr2 ” , ” qval . 2 4
↪→ hr2 ” , ”name . 2 4 hr2 ” )
myData<−lapply ( myData , GRanges )
consensus<−makeconsensus ( myData )
#################################
# Count number o f t a g s in e a ch peak
# ###############################
consensus<−as . data . frame ( consensus )
# g e t genomic r ang e s f o r e a ch sample and s t o r e in v a r i a b l e
area bed<−subset ( consensus , s e l e c t =seqnames : end )
area bed<−GRanges ( area bed )
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# s e t working d i r e c t o r y where bam f i l e s a r e
setwd ( ” / Location / BamFiles / ” )
# g e t bam f i l e s
myFiles<−as . vector ( samples$bam . f i l e )
for ( i in 1 : length ( myFiles ) ) {
count<−countarea ( myFiles [ [ i ] ] , area bed )
consensus<−append ( consensus , count )
names ( consensus )
}
consensus<−as . data . frame ( consensus )
consensus<−GRanges ( consensus )
rm ( count , area bed )
###################################
# Expor t a s c sv
# ##################################
setwd ( ” ˜ / working d i r e c t o r y ” )
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consensus<−as . data . frame ( consensus )
names ( consensus )<−c ( ” chr ” , ” s t a r t ” , ”end” , ”width” , ”
↪→ strand ” , ”merge0hr” , ”merge24hr” , ” area . 0 hr1 ” , ” area
↪→ . 0 hr2 ” , ” area . 2 4 hr1 ” , ” area . 2 4 hr2 ” )
write . csv ( consensus , f i l e =”024 hr−consensusPeak−area . csv ” )
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B.3 Annotate Peaks Using Homer Software
Homer Software Suite was used to annotate peaks. From the consensus peak
set, the unique peak name, chromosome, start, and end data was subsetted
into a new .txt file. This was then used as input for Homer annotatePeaks.pl.
After running, the annotation (HomerAnno 024hr.txt) and peak data (024hr-
consensusPeakarea.csv) are manually combined by sorting on peak name. This
will be the final dataset for analysis.
annotatePeaks . pl
a l l −for−HomerAnno . t x t hg19 > HomerAnno 024hr . t x t
−annStats HommerAnnoStats 024hr . t x t
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